id,molecule,virus,reference,type,smiles,pubchem_id,similarity_calculated
0,Remdesivir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016.0,1
1,Chloroquine,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719.0,1
2,Nitazoxanide,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-],41684.0,1
3,Nafamostat,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N,4413.0,1
4,penciclovir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO,135398748.0,1
5,nafamostat,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N,4413.0,1
6,favipiravir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,Fc1c[nH]c(=O)c(n1)C(=O)N,492405.0,1
7,Loratadine,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCOC(=O)N1CCC(=C2c3ccc(cc3CCc3c2nccc3)Cl)CC1,3957.0,1
8,Daunorubicin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1cccc2c1C(=O)c1c(C2=O)c(O)c2c(c1O)C(OC1CC(N)C(C(O1)C)O)CC(C2)(O)C(=O)C,30323.0,1
9,Midostaurin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC1C(CC2OC1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O)N(C(=O)c1ccccc1)C,9829523.0,1
10,Ponatinib,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CN1CCN(CC1)Cc1ccc(cc1C(F)(F)F)NC(=O)c1ccc(c(c1)C#Cc1cnc2n1nccc2)C,24826799.0,1
11,Silmitasertib,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Clc1cccc(c1)Nc1nc2cc(ccc2c2c1ccnc2)C(=O)O,24748573.0,1
12,Valproic Acid,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCCC(C(=O)O)CCC,3121.0,1
13,Haloperidol,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Fc1ccc(cc1)C(=O)CCCN1CCC(CC1)(O)c1ccc(cc1)Cl,3559.0,1
14,Metformin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CN(C(=N)N=C(N)N)C,4091.0,1
15,Migalastat,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,OCC1NCC(C(C1O)O)O,176077.0,1
16,S-verapamil,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1ccc(cc1OC)CCN(CCCC(c1ccc(c(c1)OC)OC)(C(C)C)C#N)C,92305.0,1
17,Indomethacin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1ccc2c(c1)c(CC(=O)O)c(n2C(=O)c1ccc(cc1)Cl)C,3715.0,1
18,Ruxolitinib,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,N#CCC(n1ncc(c1)c1ncnc2c1cc[nH]2)C1CCCC1,25126798.0,1
19,Mycophenolic acid,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1c(CC=C(CCC(=O)O)C)c(O)c2c(c1C)COC2=O,446541.0,1
20,Entacapone,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCN(C(=O)C(=Cc1cc(O)c(c(c1)[N+](=O)[O-])O)C#N)CC,5281081.0,1
21,Ribavirin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,1
22,E-52862,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Cc1cc(nn1c1ccc2c(c1)cccc2)OCCN1CCOCC1,44247568.0,1
23,Merimepodib,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1cc(ccc1c1cnco1)NC(=O)Nc1cccc(c1)CNC(=O)OC1COCC1,153241.0,1
24,RVX-208,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,OCCOc1c(C)cc(cc1C)c1nc2cc(OC)cc(c2c(=O)[nH]1)OC,135564749.0,1
25,XL413,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Clc1ccc2c(c1)c1nc([nH]c(=O)c1o2)C1CCCN1,135564632.0,1
26,AC-55541,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Brc1cccc(c1)C(=NNC(=O)C(c1n[nH]c(=O)c2c1cccc2)NC(=O)c1ccccc1)C,9589606.0,1
27,Apicidin,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCC(=O)CCCCCC1NC(=O)C2CCCCN2C(=O)C(NC(=O)C(NC1=O)Cc1cn(c2c1cccc2)OC)C(CC)C,6918328.0,1
28,AZ3451,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,N#Cc1ccc(cc1)NC(=O)c1ccc2c(c1)nc(n2C(C1CCCCC1)C)c1cc2OCOc2cc1Br,126961335.0,1
29,AZ8838,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCCc1cc(F)ccc1C(c1ncc[nH]1)O,126961334.0,1
30,Bafilomycin A1,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC1C=CC=C(C)CC(C)C(O)C(C=C(C=C(C(=O)OC1C(C(C(C1(O)CC(O)C(C(O1)C(C)C)C)C)O)C)OC)C)C,6436223.0,1
31,CCT 365623,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,NCc1ccc(s1)S(=O)(=O)c1cc(cc(c1)S(=O)(=O)C)c1ccccc1,,1
32,GB110,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,NCC1CCN(CC1)C(=O)c1cccc(c1)CNC(=O)C(C(CC)C)NC(=O)C(NC(=O)c1ccno1)CC1CCCCC1,49843508.0,1
33,H-89,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Brc1ccc(cc1)C=CCNCCNS(=O)(=O)c1cccc2c1ccnc2,449241.0,1
34,JQ1,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,O=C(OC(C)(C)C)CC1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)sc(c2C)C,46907787.0,1
35,PB28,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1cccc2c1CCCC2CCCN1CCN(CC1)C1CCCCC1,10474335.0,1
36,PD-144418,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCCN1CCC=C(C1)c1onc(c1)c1ccc(cc1)C,9817231.0,1
37,RS-PPCC,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC(=O)C1(CC1CN1CCC(CC1)(O)c1ccccc1)c1ccc(cc1)C,,1
38,TMCB,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,OC(=O)Cn1c(nc2c1c(Br)c(Br)c(c2Br)Br)N(C)C,46943415.0,1
39,UCPH-101,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1ccc(cc1)C1C2=C(OC(=C1C#N)N)CC(CC2=O)c1cccc2c1cccc2,25223366.0,1
40,ZINC1775962367,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,O=C1C[N+]2([B-](O1)(OC(=O)C2)c1ccc(cc1)Cn1c(C)nc2c1cc(Cl)c(c2[N+](=O)[O-])Cl)C,,1
41,ZINC4326719,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1cc(ccc1OC)c1nn2c(s1)nnc2c1ccco1,661498.0,1
42,ZINC4511851,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1cc(ccc1OC)c1nn2c(s1)nnc2c1cccs1,3163969.0,1
43,ZINC95559591,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,O=C(C1CCC1)NCCCNc1nc(ncc1C1CC1)Nc1ccc(cc1)N1CCOCC1,44465558.0,1
44,4E2RCat,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,S=C1SC(=Cc2ccc(o2)c2ccc(c(c2)C(=O)O)Cl)C(=O)N1Cc1ccccc1,2287236.0,1
45,ABBV-744,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCNC(=O)c1cc2c([nH]1)c(=O)n(cc2c1cc(ccc1Oc1c(C)cc(cc1C)F)C(O)(C)C)C,132010322.0,1
46,Camostat,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CN(C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c1ccc(cc1)N=C(N)N)C,2536.0,1
47,Captopril,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,SCC(C(=O)N1CCCC1C(=O)O)C,44093.0,1
48,CB5083,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,NC(=O)c1cccc2c1cc(n2c1nc(NCc2ccccc2)c2c(n1)CCOC2)C,73051434.0,1
49,Chloramphenicol,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,OCC(C(c1ccc(cc1)[N+](=O)[O-])O)NC(=O)C(Cl)Cl,5959.0,1
50,Chloroquine,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719.0,1
51,Compound 10,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC=C(c1ccccc1Oc1nc[nH]c(=O)c1)C(=O)OO,139595720.0,1
52,Compound 2,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CO[C@@H]1CC/C=C/c2cccc(c2)[C@@H](CCNC(=O)OC(C)(C)C)OC(=O)[C@H]2NN(C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]1C)C(C)C)C)CCC2,,1
53,CPI-0610,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,NC(=O)CC1N=C(c2ccc(cc2)Cl)c2c(c3c1onc3C)cccc2,57389999.0,1
54,Dabrafenib,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Nc1nccc(n1)c1sc(nc1c1cccc(c1F)NS(=O)(=O)c1c(F)cccc1F)C(C)(C)C,44462760.0,1
55,DBeQ,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,c1ccc(cc1)CNc1nc(NCc2ccccc2)c2c(n1)cccc2,676352.0,1
56,dBET6,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,O=C(COc1cccc2c1C(=O)N(C2=O)C1CCC(=O)NC1=O)NCCCCCCCCNC(=O)CC1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)sc(c2C)C,121427831.0,1
57,IHVR-19029,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,OC[C@H]1N(CCCCCCN(C(=O)NC(C)(C)C)C2CCCCC2)C[C@@H]([C@H]([C@@H]1O)O)O,,1
58,Linezolid,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC(=O)NCC1OC(=O)N(C1)c1ccc(c(c1)F)N1CCOCC1,441401.0,1
59,Lisinopril,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,NCCCCC(C(=O)N1CCCC1C(=O)O)NC(C(=O)O)CCc1ccccc1,5362119.0,1
60,Minoxidil,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Nc1cc(nc(=N)n1O)N1CCCCC1,4201.0,1
61,ML240,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1cccc2c1nc(nc2NCc1ccccc1)n1c(N)nc2c1cccc2,49830258.0,1
62,MZ1,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,O[C@@H]1C[C@H](N(C1)C(=O)[C@H](C(C)(C)C)NC(=O)COCCOCCOCCNC(=O)C[C@@H]1N=C(c2ccc(cc2)Cl)c2c(n3c1nnc3C)sc(c2C)C)C(=O)NCc1ccc(cc1)c1scnc1C,,1
63,Nafamostat,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,NC(=Nc1ccc(cc1)C(=O)Oc1ccc2c(c1)ccc(c2)C(=N)N)N,4413.0,1
64,Pevonedistat,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,OC1CC(CC1COS(=O)(=O)N)n1ccc2c1ncnc2NC1CCc2c1cccc2,16720766.0,1
65,PS3061,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,N#CCC[C@H]1OC(=O)[C@H](C)N(C)C(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc2cn(c3c2cccc3)Cc2ccc(cc2)Br)N(C(=O)[C@@H](NC(=O)[C@@H](N(C(=O)[C@@H](NC1=O)CC(C)C)C)CC(C)C)CC(C)C)C,,1
66,Rapamycin (Sirolimus),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COC1CC(CCC1O)CC(C1OC(=O)C2CCCCN2C(=O)C(=O)C2(O)OC(CCC2C)CC(OC)C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)C1)C)C)O)OC)C)C)C)C,5284616.0,1
67,Sanglifehrin A,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CCC1CC(C)C2(NC1=O)OC(CC(C(CCC=CC=C(C1CC=CC=CC(O)C(C)C(O)C(CCC(=O)C)C(=O)NC(C(=O)NC(C(=O)N3NC(C(=O)O1)CCC3)Cc1cccc(c1)O)C(C)C)C)C)O)C(C(C2C)O)C,5388925.0,1
68,Sapanisertib (INK128/MlN128),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Nc1oc2c(n1)cc(cc2)c1nn(c2c1c(N)ncn2)C(C)C,,1
69,FK-506 (Tacrolimus),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C=CCC1C=C(C)CC(C)CC(OC)C2OC(O)(C(CC2OC)C)C(=O)C(=O)N2C(C(=O)OC(C(C(CC1=O)O)C)C(=CC1CCC(C(C1)OC)O)C)CCCC2,445643.0,1
70,Ternatin 4 (DA3),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,C=C[C@@H](C[C@@H]1NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C)N(C)C(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H]2N(C(=O)[C@@H](N(C1=O)C)C)CCCC2)[C@@H](C(C)C)O)[C@H](CC)C)C,,1
71,Tigecycline,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,O=C(Nc1cc(N(C)C)c2c(c1O)C(=C1C(C2)CC2C(C1=O)(O)C(=C(C(=O)C2N(C)C)C(=O)N)O)O)CNC(C)(C)C,54686904.0,1
72,Tomivosertib (eFT-508),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,Nc1ncnc(c1)Nc1cc(C)c2n(c1=O)C1(CCCCC1)NC2=O,,1
73,Verdinexor,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,O=C(C=Cn1cnc(n1)c1cc(cc(c1)C(F)(F)F)C(F)(F)F)NNc1ccccn1,71492799.0,1
74,WDB002,SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,CC[C@@H]([C@@H]1/C=C/C/C=C/C[C@@H](C)[C@H](O)[C@H]([C@H]2O[C@](C(=O)C(=O)N3[C@H](C(=O)O1)CCCC3)(O)[C@H](C)CC2)C)Cc1ccccc1,,1
75,Zotatifin (eFT226),SARS-CoV-2,10.1101/2020.03.22.002386v1,experimental,COc1nc(OC)cc2c1[C@]1(O)[C@H](O)[C@@H]([C@H]([C@@]1(O2)c1ccc(cc1)C#N)c1ccccc1)CN(C)C,,1
76,Camostat,MERS,10.3390/v10120721,experimental,CN(C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c1ccc(cc1)N=C(N)N)C,2536.0,1
77,Chloroquine,MERS,10.3390/v10120721,experimental,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,2719.0,1
78,Chlorpromazine,MERS,10.3390/v10120721,experimental,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,2726.0,1
79,Ouabain,MERS,10.3390/v10120721,experimental,OCC12C(O)CC(CC2(O)CCC2C1C(O)CC1(C2(O)CCC1C1=CC(=O)OC1)C)OC1OC(C)C(C(C1O)O)O,439501.0,1
80,bufalin,MERS,10.3390/v10120721,experimental,OC1CCC2(C(C1)CCC1C2CCC2(C1(O)CCC2c1ccc(=O)oc1)C)C,9547215.0,1
81,Dihydrotanshinone,MERS,10.3390/v10120721,experimental,CC1COC2=C1C(=O)C(=O)c1c2ccc2c1cccc2C,5316743.0,1
82,Disulfiram,MERS,10.3390/v10120721,experimental,CCN(C(=S)SSC(=S)N(CC)CC)CC,3117.0,1
83,6-thioguanine,MERS,10.3390/v10120721,experimental,Nc1nc(=S)c2c([nH]1)nc[nH]2,,1
84,mycophenolic acid,MERS,10.3390/v10120721,experimental,COc1c(C/C=C(/CCC(=O)O)\C)c(O)c2c(c1C)COC2=O,,1
85,Promethazine,MERS,10.3390/v10120721,experimental,CN(C(CN1c2ccccc2Sc2c1cccc2)C)C,4927.0,1
86,fluphenazine,MERS,10.3390/v10120721,experimental,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F,3372.0,1
87,Ribavirin,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,1
88,Lopinavir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,1
89,ritonavir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,1
90,Penciclovir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO,135398748.0,1
91,Nitazoxanide,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-],41684.0,1
92,Chloroquine,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719.0,1
93,Remdesivir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,CCC(COC(=O)[C@@H](N[P@@](=O)(Oc1ccccc1)OC[C@H]1O[C@@]([C@@H]([C@@H]1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,,1
94,Favipiravir,SARS-CoV-2,10.1038/s41422-020-0282-0,experimental,Fc1c[nH]c(=O)c(n1)C(=O)N,492405.0,1
95,Ribavirin,SARS,10.3201/eid1004.030458,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,1
96,Oseltamivir,SARS,10.3201/eid1004.030458,experimental,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028.0,1
97,Foscarnet,SARS,10.3201/eid1004.030458,experimental,OC(=O)P(=O)(O)O,3415.0,1
98,EGCG Palmitate,SARS,10.2174/1871528114666151022150122,experimental,Oc1cc(O)c2c(c1)O[C@@H]([C@@H](C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O,,1
99,glycyrrhizin,SARS,10.1021/jm0493008,experimental,O[C@@H]1[C@@H](O[C@@H]2O[C@H](C(=O)O)[C@H]([C@@H]([C@H]2O)O)O)[C@H](O[C@@H]([C@H]1O)C(=O)O)O[C@H]1CC[C@]2([C@H](C1(C)C)CC[C@@]1([C@@H]2C(=O)C=C2[C@@]1(C)CC[C@@]1([C@H]2C[C@](C)(CC1)C(=O)O)C)C)C,,1
100,zanamivir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,OCC(C(C1OC(=CC(C1NC(=O)C)N=C(N)N)C(=O)O)O)O,60855.0,1
101,oseltamivir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028.0,1
102,arbidol,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411.0,1
103,Lamivudine,SARS-CoV-2,10.5582/bst.2020.01020,experimental,Nc1ccn(c(=O)n1)C1CSC(O1)CO,60825.0,1
104,lopinavir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,1
105,ritonavir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,1
106,Umifenovir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411.0,1
107,hydroxychloroquine,SARS-CoV-2,10.5582/bst.2020.01020,experimental,OCCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,3652.0,1
108,chloroquine,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719.0,1
109,remdesivir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016.0,1
110,arbidol,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411.0,1
111,lopinavir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,1
112,ritonavir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,1
113,darunavir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,213039.0,1
114,cobicistat,SARS-CoV-2,10.5582/bst.2020.01020,experimental,O=C(NC(Cc1ccccc1)CCC(Cc1ccccc1)NC(=O)C(NC(=O)N(Cc1csc(n1)C(C)C)C)CCN1CCOCC1)OCc1cncs1,25151504.0,1
115,favipiravir,SARS-CoV-2,10.5582/bst.2020.01020,experimental,Fc1c[nH]c(=O)c(n1)C(=O)N,492405.0,1
116,thalidomide,SARS-CoV-2,10.5582/bst.2020.01020,experimental,O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)cccc2,5426.0,1
117,vitamin C,SARS-CoV-2,10.5582/bst.2020.01020,experimental,OCC(C1OC(=O)C(=C1O)O)O,54670067.0,1
118,methylpredinsone,SARS-CoV-2,10.5582/bst.2020.01020,experimental,OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)CC(=O)[C@H]1[C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)C,,1
119,pirfenidone,SARS-CoV-2,10.5582/bst.2020.01020,experimental,Cc1ccc(=O)n(c1)c1ccccc1,40632.0,1
120,bromhexine hydrochloride,SARS-CoV-2,10.5582/bst.2020.01020,experimental,Brc1cc(CN(C2CCCCC2)C)c(c(c1)Br)N.Cl,5702220.0,1
121,Fingolimod,SARS-CoV-2,10.5582/bst.2020.01020,experimental,CCCCCCCCc1ccc(cc1)CCC(CO)(CO)N,107970.0,1
122,INSC-1,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)N1CCN(CC1)Cc1cc(F)ccc1CN1CCC2(CC1)NC(=O)c1n2ccc1[C@H](NS(=O)(=O)c1ccccc1)C,,1
123,INSC-2,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1cccc(c1)[C@@H](CN1CCC(CC1)NC(=O)[C@@H](C(C)C)NC(=O)c1nn(c2c1CCC2)c1cccc(c1)F)C,,1
124,INSC-3,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(C[C@@]1(CCOc2c1cccc2)NC(=O)Nc1cccc(c1)C1(N)CC1)NC[C@H](C(C)C)NC(=O)c1csc(c1)C,,1
125,INSC-4,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C1Nc2c(cccc2[C@@H]2N1CCN(C2)C(=O)c1c(C)cccc1F)NC(=O)C(N)(C)C,,1
126,INSC-5,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cccc(c1)[C@@H]1CC2(NS1(=O)=O)CN(C2)c1ccc(c(c1)C)C(=O)N1CCN(C(=O)C1)c1ccc(cc1)F,,1
127,INSC-6,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1ccc(cc1)S(=O)(=O)N[C@H](c1ccccc1)C(=O)Nc1ccc(cc1)c1c(cc[nH]c1=O)CN1CCC(CC1)(F)F,,1
128,INSC-7,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CNCS(=O)(=O)Nc1cccc(c1)NC(=O)c1cn(c2c1cccc2)C[C@H](c1ccc(cc1)C(F)(F)F)O,,1
129,INSC-8,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(c1ccc(cc1)[C@]1(C)NC(=O)N(C1=O)Cc1ccc(c(c1)F)C)N1CCC2(CC1)C[C@H](C(=O)N2)c1ccc(c(c1)C)O,,1
130,INSC-9,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Oc1ccc(cc1)[C@@H]1CC2(NC1=O)CCN(CC2)C(=O)c1ccc(cc1C)[C@]1(C)NC(=O)N(C1=O)Cc1cccc(c1)O,,1
131,INSC-10,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1cccc(c1)c1n[nH]c2c1CN(C2=O)c1ccn2c1NC(=O)[C@@]12CCN1CCC(=O)c1ccc(s1)C,,1
132,INSC-11,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CN1CCC2(CC1)[C@H](NC(=O)N2C[C@H](c1cccc2c1cco2)C)c1ccc(cc1)S(=O)(=O)Nc1ccc(cc1)C,,1
133,INSC-12,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1ccc(cc1)S(=O)(=O)N[C@H](c1ccccc1F)C(=O)Nc1ccc(cc1)c1c(cc[nH]c1=O)CN1CCCCC1,,1
134,INSC-13,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCC[C@@H](c1ccc(cc1)F)C(=O)Nc1ccc(c(c1)c1ccnc(c1)C)CN1C(=O)CCC1=O,,1
135,INSC-14,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C([C@@H](N)C)Nc1cccc2c1NC(=O)C1N2CCN(C1)C(=O)c1ccc(s1)c1ccc(cc1)F,,1
136,INSC-15,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COCc1cccc(c1O)c1n[nH]c2c1CN(C2=O)C(=O)N[C@H](C[C@@H](c1scnc1C(C)C)N)C,,1
137,INSC-16,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Cc1ccc(cc1)C1=NS(=O)(=O)C2=C(N1)CC[C@]2(C)C1CCN(CC1)C[C@@H]1CCCN(C1)c1nc2c([nH]1)cccc2,,1
138,INSC-17,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCCOC(=O)[C@H]1CC[C@@H]1c1nc2c([nH]1)CCN(C2)c1ccc(cc1NS(=O)(=O)c1ccc(nc1)C)C(F)(F)F,,1
139,INSC-18,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Oc1cccc(c1)NC(=O)c1ccc(c2c1[nH]c(c2)[C@@H](N1CCC2(CC1)NC(=O)c1c(O2)cccc1)C(=O)N)O,,1
140,INSC-19,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1ccsc1C(=O)CCN1CC[C@@H]2[C@@H](C1=O)c1[nH]nc(c1C2)c1cc(O)cc(c1)F,,1
141,INSC-20,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(C(C)C)NC1CCN(CC1)[C@@]1(CC[C@H]1C[C@H]1Nc2ccccc2S(=O)(=O)N1C)Cc1cc(F)ccc1O,,1
142,INSC-21,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCS(=O)(=O)Nc1ccc2c(c1)NC(=O)[C@@]1(C2)CN(C[C@H](c2cc(C)cc(c2)O)O)C(=O)c2c1cccc2,,1
143,INSC-22,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc(F)cc(c1)c1n[nH]c2c1CC(C)(C)N(C2=O)C(=O)NCCCC(=O)c1cnc(s1)C,,1
144,INSC-23,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1ccc(cc1)CCC[C@@H]1OC2=C(C(=O)N)N(CN2C1=O)C(=O)c1cc2c(s1)cccc2,,1
145,INSC-24,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)Nc1ccc(cc1)n1c(C)nc2c1C(=O)N[C@H](N2C)C1=COC[C@H](C1)c1cccc(c1)F,,1
146,INSC-25,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OC[C@@H](S(=O)(=O)NCC1CCC(CC1)c1[nH]c(c(n1)c1cccc(c1C)O)C)c1cccnc1,,1
147,INSC-26,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Oc1ccc(c(c1)NC(=O)c1cc(C)cc2c1[nH]c(c2)C(=O)N1CC[C@]2(C1)NC(=O)c1c(O2)cccc1)Cl,,1
148,INSC-27,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc2c(n1CC(=O)OCC(=O)NC[C@@H]1[C@H](O)C[C@@H]1NC(=O)Nc1cccc(c1)F)cccc2,,1
149,INSC-28,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C([C@H]1[C@@H](Cc2c(C31CCN(CC3)C(=O)Nc1ccc(c(c1)C)F)cc([nH]2)C)C(=O)N)Oc1c[nH]ccc1=O,,1
150,INSC-29,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCc1c(C)ncc2c1cc(C(=O)N[C@H](C(=O)N[C@@]1(CCCOC1)/C=C/C(=O)NCc1ccccc1O)C1CCC1)c(c2)[C@H](O)C,,1
151,INSC-30,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCCc1nc2ccccc2c(c1CO)C(=O)N[C@H](C(=O)N[C@@H](c1ccc(cc1)O)/C=C/C(=O)NCc1cccc(c1)F)CC(C)C,,1
152,INSC-31,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCc1cnn2c1c(CO)c(cc2C)C(=O)N[C@@H]([C@H]1CC1(C)C)C(=O)N[C@@H](c1ccc(cc1)O)/C=C/C(=O)NCc1ccccc1,,1
153,INSC-32,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1ccc(c(c1)F)S(=O)(=O)N[C@](c1ccncc1F)(C(=O)N[C@@]1(C[C@@H](C1)C(F)(F)F)C(=O)NC/C=C/C(=O)NCc1ccc(cc1)Cl)C,,1
154,INSC-33,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(/C=C/[C@H](c1ccc(cc1)O)NC(=O)C1(NC(=O)c2cc3c(N)cn(c3cc2C)C)CC(C1)(C)C)NCc1cccc(c1)F,,1
155,INSC-34,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(NCc1ccccc1)/C=C/[C@H]([C@H]1CCOC1)NC(=O)C1(CC1)NC(=O)c1cc2CNCCc2cc1C,,1
156,INSC-35,SARS-CoV-2,10.1101/2020.03.03.972133,computational,C[C@@H]1C[C@@](C1)(NC(=O)c1cn2c(N)ncc2cc1C)C(=O)N[C@@H](c1ccnnc1)/C=C/C(=O)NCc1ccc(cc1)O,,1
157,INSC-36,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(NC1(CCOCC1)C(=O)N[C@@H](c1ccncn1)/C=C/C(=O)OCc1ccccc1)NCc1ccc2c(c1)OCCN2,,1
158,INSC-37,SARS-CoV-2,10.1101/2020.03.03.972133,computational,C[C@@H](Cc1cn[nH]c1C)NC(=O)NC1(CCCCC1)C(=O)N[C@H](c1c[nH]cc1)/C=C/C(=O)Oc1ccccc1,,1
159,INSC-38,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC1CCN(CC1)C(=O)c1ccc(cc1)NC(=O)CNC(=O)c1csc(n1)NC(=O)C1(CCC1)c1cccnc1,,1
160,INSC-39,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(Nc1ccc(cc1)F)Nc1cc(C)c(c(c1)F)c1nc(cnc1OCC1CC1)OCC1(O)CCN(CC1)C1CCC1,,1
161,INSC-40,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cccc(c1)[C@](NC(=O)N[C@H]1C[C@H](c2c1c(cc(c2)F)C(=O)Cc1ccccc1OC)O)(CO)C,,1
162,INSC-41,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc(OCC(=O)N)cc(c1)[C@@H](c1ccc(c(c1)C)OC)NC(=O)[C@@H](C(F)(F)F)C(=O)NCC(=O)O,,1
163,INSC-42,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OC[C@H](C[C@H](C(=O)Nc1ccc(c(c1)F)O)NC(=O)Cc1noc(n1)c1ccc(cc1)C(=O)NCC(C)C)C,,1
164,INSC-43,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1cc(cc(c1)S(=O)(=O)[C@@H]1CC[C@@H]([C@H]1C)N)c1[nH]c(=O)c2n(c1)ccc2Cc1cccc2c1nc([nH]2)C,,1
165,INSC-44,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OCC1(CCN(CC1)Cc1noc(n1)c1cc(ccc1C)C(=O)N1CCOCC1)CCc1ccc(c(c1)F)O,,1
166,INSC-45,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(c1cc(O)c(c(c1)F)O)N[C@@H]1CCC[C@@]2(C1)CC[C@H](S(=O)(=O)N2)N1CCN(CC1)c1ccccc1Cl,,1
167,INSC-46,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)N[C@@H](C(=O)Nc1cc(ccc1C)C1=NNS(=O)(=O)C2=C1CCC(=O)N2c1ccc(cc1)F)Cc1ccc(cc1F)C,,1
168,INSC-47,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OC[C@@H]1CC[C@H](CC1)N(C(=O)c1nn(c(c1)C)C(=O)CC)c1nc2c(s1)c(ccc2)C(OC)(F)F,,1
169,INSC-48,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)Nc1ccc(cc1)C(=O)N[C@@]1(CC[C@@H](CC1)O)C(=O)Nc1ccc(cc1)C(=O)NCc1ccc(cn1)F,,1
170,INSC-49,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)N1C[C@H]([C@](C1)(O)C(=O)Nc1ccc(cc1)c1nnc(o1)C)C(=O)Nc1ccc(cc1)NC,,1
171,INSC-50,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OCCN1CCN(CC1)c1ccccc1NC(=O)c1ccc(cc1)NC(=O)C(NCc1[nH]c2c(c1)cc(cc2)F)(C)C,,1
172,INSC-51,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC[C@@H](c1ccc(cc1)Cl)CC(=O)N(c1sc2c(n1)c(OC)ccc2O)CCN1CC[C@@]21C[C@H]2N,,1
173,INSC-52,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(NCC1(N)CC1)NCc1c(C)cc(cc1F)C(=O)N[C@H](c1c(Cl)cccc1C(F)(F)F)[C@@H]1CCCO1,,1
174,INSC-53,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC(CNC(=O)[C@H](N1C(=O)N[C@@](c2c1cc(cc2)C(=O)N1CCCC1)(Cc1ccc(cc1)F)C(=O)NCC1(O)CCC(CC1)(F)F)c1ccc(cc1)O)C,,1
175,INSC-54,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(Nc1ccc(c2c1CCC2)NC(=O)C(C(=O)N1CCC[C@H]1C(=O)c1ccc(cc1Cl)O)(C)C)Nc1ccc(cc1)F,,1
176,INSC-55,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CNc1ccc(c(c1)OC[C@H]([C@@H]1C[C@H](C1)CC(=O)n1nnc2c1ccc(c2OC(c1ccc(cc1)OC)(F)F)O)O)F,,1
177,INSC-56,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCOC(=O)c1noc(n1)[C@H](c1cc(O)ccc1OC1(CCCC1)C1CC1)N[C@@H](CCc1ncc([nH]1)C)C,,1
178,INSC-57,SARS-CoV-2,10.1101/2020.03.03.972133,computational,C[C@@H](CCc1cc(O)cc(c1Cl)c1nc(=O)n(c2c1C(=O)N([C@H]2N(Cc1ccccc1F)C)C)C)N,,1
179,INSC-58,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Oc1cc(CC[C@@](CCc2ccc(c(c2)F)O)(N)C)c(c(c1)c1ncc(=O)n2c1C(=O)C[C@@]12COCCO1)C,,1
180,INSC-59,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCCNS(=O)(=O)c1ccc2c(c1)CN(C[C@]2(C)C(=O)c1cnc2n1ccc(c2)O)Cc1ccc(s1)C,,1
181,INSC-60,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCNC(=O)c1ccc(c(c1)NC(=O)c1ccc(cc1)[C@](c1ccc(cc1F)O[C@@H](C(=O)N[C@H]1CCS(=O)(=O)C1)CC)(O)C)C,,1
182,INSC-61,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NC(=O)Nc1ccc(cc1)[C@@H](c1c(nc2c(c1CN1CCCC1)cccc2)C(=O)N1CC[C@H]([C@@](C1)(C)O)Cc1ccc(cc1)F)O,,1
183,INSC-62,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O[C@H]1CC[C@@H](C1)N[C@H](C1(CCN(CC1)C)Cc1onc(c1)c1ccc(cc1F)F)C(=O)Nc1cc(n(c1)C)O,,1
184,INSC-63,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1ccc(cc1C[C@]1(COCC1)CNC(=O)c1scc(n1)C(=O)OCCNc1ccc(nc1)C)O,,1
185,INSC-64,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1ccc2c(c1)NC(=O)[C@H]2CC(=O)N1CCC(CC1)(O)c1ccc2c(c1)nc([nH]2)c1ccc(cc1O)F,,1
186,INSC-65,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O[C@@H]1CC[C@H](CC1)NC(=O)[C@@H](S(=O)(=O)c1ccc(c(c1)C)NC(=O)NCc1ccc(cc1)C(F)(F)F)C,,1
187,INSC-66,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc(O)ccc1CNC(=O)c1cc(ccc1NC(=O)CC1CC1)N1C(=O)N[C@@](C1=O)(C)c1ccc(cc1)F,,1
188,INSC-67,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CN1CCC(=CC1)Cc1ccncc1S(=O)(=O)c1ncccc1O[C@@H]1CCN(C1)[C@@H](C(=O)Nc1ccc(c(c1)F)C1(C)CCOCC1)C,,1
189,INSC-68,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OCc1nsc(c1C(=O)N[C@H]1COCC1)N[C@H]1CCCC[C@H]1C(=O)Nc1c(C)sc2c1cccc2,,1
190,INSC-69,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COCC(=O)N[C@@]1(CC[C@H](C1)O)C(=O)Nc1ccc(cc1OC)CNc1cc([nH]c1C)c1ccc(cc1)F,,1
191,INSC-70,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NC[C@H]1CCN(C1)C(=O)c1cc(ccc1NC(=O)N1CCCC1)C(=O)NCc1ccc(cc1)C(F)(F)F,,1
192,INSC-71,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CNCc1cccn1c1ccc(c(c1)F)NC(=O)[C@@H]1C[C@@H](CN1c1cccc(c1)NC(=O)Nc1ccc2c(c1)OCCO2)O,,1
193,INSC-72,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CNc1cc(n2c1cncc2)NC(=O)[C@@H](C1(CCN(CC1)C(=O)C)Cc1onc(c1)c1ccc(cc1F)F)N[C@H]1CC[C@@H](C1)O,,1
194,INSC-73,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1cc2c(c(c1)c1cncc(c1C)CCC1(N)COC1)C(=O)NC12CCCCC1,,1
195,INSC-74,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1ccc(cc1)[C@H]1C[C@]1(N)CCc1cc(O)cc(c1C)c1nc2N(C)C(=O)C[C@@H](c2c(=O)[nH]1)C(F)(F)F,,1
196,INSC-75,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CNC(=O)[C@@H](c1cncc(c1)C1(N)CC1)N[C@@H]([C@@H]1Cc2c(C1)cccc2NC(=O)N1CC(C1)O)C,,1
197,INSC-76,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O[C@H]1[C@H](CC21C[C@H](C2)CC(=O)n1cnc2c1cccc2C#Cc1ccncc1)C(=O)N(C1CC1)C,,1
198,INSC-77,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(C1CCC1)N[C@@H]1CCC[C@@]2(C1)C[C@@H](S(=O)(=O)N2)N1CCN(CC1)c1cccnc1,,1
199,INSC-78,SARS-CoV-2,10.1101/2020.03.03.972133,computational,Fc1cc(cc(c1)c1ccc(cc1C)F)C(=O)Nc1cccc(c1)NC(=O)C1(N)CC1,,1
200,INSC-79,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc(F)ccc1[C@H](C(=O)NCC(=O)N1CC[C@H](C1)c1ccc2c(c1)nc([nH]2)c1ccc(cc1C)F)CNC(C)C,,1
201,INSC-80,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCc1ccc(cc1)N[C@@H]1NC(=O)N(C21CCC2)C[C@H]([C@H](Cc1ccc(cc1)F)NC(=O)C1CC1)O,,1
202,INSC-81,SARS-CoV-2,10.1101/2020.03.03.972133,computational,COc1cc(O)ccc1NC(=O)N(CC(=O)N(C1(C)CC1)Cc1nccc(c1)C)CCN1CCOCC1,,1
203,INSC-82,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CN1CCC(CC1)c1nccc(c1C(=O)CCCc1ccc2c(c1)S(=O)(=O)CCN2C(=O)Cc1ccc(cc1)O)c1ccc(cc1)F,,1
204,INSC-83,SARS-CoV-2,10.1101/2020.03.03.972133,computational,OCC(c1cccc2c1CN(CC12CN(C1)C)C(=O)N[C@@H]([C@H]1CCOC1)CCC1(N)CC1)c1[nH]c2c(n1)ccc(c2)F,,1
205,INSC-84,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCC(=O)c1c(F)cccc1N(C(=O)Nc1ccc2c(c1)[C@H](CC2)C(=O)c1ccc2c(c1)CCN2)C,,1
206,INSC-85,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(Nc1c(O)ccc(c1C)O)Nc1ccc2c(c1)[C@H](OC2)C(=O)c1c(cncc1C1CCNCC1)Nc1ccc(cc1F)F,,1
207,INSC-86,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCC(=O)N[C@H]([C@@H](C[C@H]1CCC2=C1S(=O)(=O)N=C(N2)c1cccc(c1)Cc1cc(F)c(c(c1)F)N1CCN(CC1)C)O)Cc1ccc(cc1)F,,1
208,INSC-87,SARS-CoV-2,10.1101/2020.03.03.972133,computational,C[C@@H](Cc1cccc(c1)F)NC[C@@H]1COCC[C@@]21NC(=O)N(C2=O)c1ccc(cc1Cl)CNC(=O)C1CC1,,1
209,INSC-88,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CCS(=O)(=O)N1CCc2c1ccc1c2[C@H](CC1)C(=O)c1c(cncc1c1cccc(c1C)F)C1CCN(CC1)C,,1
210,INSC-89,SARS-CoV-2,10.1101/2020.03.03.972133,computational,N[C@@H](Cc1ccc([nH]1)C)CCNC1=CC=C(S(=O)(=O)N1C)c1cc(NC(=O)C2CC2)c(cc1Cl)C,,1
211,INSC-90,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC(C[C@@H]1NC(=O)[C@H](CCOCc2n(C[C@H](NC1=O)/C=C/C(=O)OCc1ccccc1)c(=O)[nH]c2)NC(=O)[C@H](C(F)(F)F)N)C,,1
212,INSC-91,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C(/C=C/[C@@H]1CN2C[C@H](CCC[C@@H](C(=O)N[C@H](C(=O)N1)CC(C)C)NC(=O)[C@@H](Nc1ccccc1)C)CNC2=O)OCc1ccccc1,,1
213,INSC-92,SARS-CoV-2,10.1101/2020.03.03.972133,computational,O=C([C@H](C(F)(F)F)Nc1ccccc1)N[C@H]1CCC[C@@H]2CNC(=O)N(C2)C[C@H](NC(=O)[C@@H](NC1=O)CC(F)(C)C)/C=C/C(=O)c1cnn[nH]1,,1
214,INSC-93,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC[C@@H](Nc1nc(nc2c1C(=O)C(=C)C[C@]1(O2)CCNC1=O)c1ccc([nH]1)[C@@H](NC(=O)c1nccs1)CC)C,,1
215,INSC-94,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC(CNc1nc(nc2c1C(=O)C(=C)C(=O)[C@]1(O2)CCNC1=O)C(=O)NC[C@H](C(F)(F)F)O)C,,1
216,INSC-95,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CC(CNc1nc(nc2c1C(=O)C(=C)C(=O)[C@]1(O2)CCNC1=O)n1c(C)cc2c1cccc2)C,,1
217,INSC-96,SARS-CoV-2,10.1101/2020.03.03.972133,computational,NCC(=O)N[C@@]12CCN(C1)CCC/C=C/C[C@H](NC(=O)[C@@H](NC2=O)CC(C)C)/C=C/C(=O)OCc1ccccc1,,1
218,INSC-97,SARS-CoV-2,10.1101/2020.03.03.972133,computational,CN[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C/C=C\CC[C@H]2[C@@H]1C2)/C=C/C(=O)OCc1ccccc1,,1
219,Glycyrrhizin,SARS,10.1016/j.jcv.2004.03.003,experimental,OC1C(OC2OC(C(=O)O)C(C(C2O)O)O)C(OC(C1O)C(=O)O)OC1CCC2(C(C1(C)C)CCC1(C2C(=O)C=C2C1(C)CCC1(C2CC(C)(CC1)C(=O)O)C)C)C,14982.0,1
220,Ribavirin,SARS,10.1016/j.jcv.2004.03.003,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,1
221,Lopinavir,SARS,10.1016/j.jcv.2004.03.003,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,1
222,Rimantadine,SARS,10.1016/j.jcv.2004.03.003,experimental,CC(C12CC3CC(C2)CC(C1)C3)N,5071.0,1
223,Baicalin,SARS,10.1016/j.jcv.2004.03.003,experimental,OC(=O)C1OC(Oc2cc3oc(cc(=O)c3c(c2O)O)c2ccccc2)C(C(C1O)O)O,64982.0,1
224,Dihydrotanshinone,MERS,10.1016/j.ijantimicag.2018.05.003,experimental,CC1COC2=C1C(=O)C(=O)c1c2ccc2c1cccc2C,5316743.0,1
225,Ribavirin,SARS,10.1371/journal.pmed.0030343,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,1
226,Lopinavir,SARS,10.1371/journal.pmed.0030343,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,1
227,Ribavirin,MERS,nrd.2015.37,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,1
228,Lopinavir,MERS,nrd.2015.37,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,1
229,ritonavir,MERS,nrd.2015.37,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,1
230,hydrocortisone,MERS,nrd.2015.37,experimental,OCC(=O)C1(O)CCC2C1(C)CC(O)C1C2CCC2=CC(=O)CCC12C,5754.0,1
231,methylprednisolone,MERS,nrd.2015.37,experimental,OCC(=O)C1(O)CCC2C1(C)CC(O)C1C2CC(C2=CC(=O)C=CC12C)C,6741.0,1
232,Nitazoxanide A,MERS,nrd.2015.37,experimental,CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-],,1
233,Chlorpromazine,MERS,nrd.2015.37,experimental,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,2726.0,1
234,Ouabain,MERS,nrd.2015.37,experimental,OCC12C(O)CC(CC2(O)CCC2C1C(O)CC1(C2(O)CCC1C1=CC(=O)OC1)C)OC1OC(C)C(C(C1O)O)O,439501.0,1
235,Bufalin,MERS,nrd.2015.37,experimental,OC1CCC2(C(C1)CCC1C2CCC2(C1(O)CCC2c1ccc(=O)oc1)C)C,9547215.0,1
236,Chloroquine,MERS,nrd.2015.37,experimental,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719.0,1
237,Camostat mesylate,MERS,nrd.2015.37,experimental,CS(=O)(=O)O.CN(C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c1ccc(cc1)N=C(N)N)C,5284360.0,1
238,Trametinib,MERS,nrd.2015.37,experimental,CC(=O)Nc1cccc(c1)n1c(=O)n(C2CC2)c(=O)c2c1c(C)c(=O)n(c2Nc1ccc(cc1F)I)C,11707110.0,1
239,Selumetinib,MERS,nrd.2015.37,experimental,OCCONC(=O)c1cc2n(C)cnc2c(c1Nc1ccc(cc1Cl)Br)F,10127622.0,1
240,Everolimus,MERS,nrd.2015.37,experimental,OCCOC1CCC(CC1OC)CC(C1OC(=O)C2CCCCN2C(=O)C(=O)C2(O)OC(CCC2C)CC(OC)C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)C1)C)C)O)OC)C)C)C)C,6442177.0,1
241,Rapamycin,MERS,nrd.2015.37,experimental,COC1CC(CCC1O)CC(C1OC(=O)C2CCCCN2C(=O)C(=O)C2(O)OC(CCC2C)CC(OC)C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)C1)C)C)O)OC)C)C)C)C,5284616.0,1
242,Dasatinib,MERS,nrd.2015.37,experimental,OCCN1CCN(CC1)c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl,3062316.0,1
243,Imatinib,MERS,nrd.2015.37,experimental,CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C,5291.0,1
244,Ribavirin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,1
245,Valganciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(OCn1cnc2c1nc(N)[nH]c2=O)COC(=O)C(C(C)C)N,135413535.0,1
246,β-Thymidine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(CC1O)n1cc(C)c(=O)[nH]c1=O,,1
247,Aspartame,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC(=O)C(NC(=O)C(CC(=O)O)N)Cc1ccccc1,134601.0,1
248,Oxprenolol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C=CCOc1ccccc1OCC(CNC(C)C)O,4631.0,1
249,Doxycycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN(C1C(=O)C(=C(C2(C1C(O)C1C(C)c3cccc(c3C(=C1C2=O)O)O)O)O)C(=O)N)C,54671203.0,1
250,Acetophenazine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCCN1CCN(CC1)CCCN1c2ccccc2Sc2c1cc(cc2)C(=O)C,17676.0,1
251,Iopromide,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COCC(=O)Nc1c(I)c(C(=O)NCC(CO)O)c(c(c1I)C(=O)N(CC(CO)O)C)I,3736.0,1
252,Riboflavin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(C(C(Cn1c2cc(C)c(cc2nc2c1nc(=O)[nH]c2=O)C)O)O)O,493570.0,1
253,Reproterol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Oc1cc(O)cc(c1)C(CNCCCn1cnc2c1c(=O)n(C)c(=O)n2C)O,25654.0,1
254,"2,2′-Cyclocytidine",SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC2C(C1O)Oc1n2ccc(=N)n1,,1
255,Chloramphenicol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(C(c1ccc(cc1)[N+](=O)[O-])O)NC(=O)C(Cl)Cl,5959.0,1
256,Chlorphenesin carbamate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(COC(=O)N)COc1ccc(cc1)Cl,2724.0,1
257,Levodropropizine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(CN1CCN(CC1)c1ccccc1)O,65859.0,1
258,Cefamandole,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(C(=O)NC1C(=O)N2C1SCC(=C2C(=O)O)CSc1nnnn1C)c1ccccc1,456255.0,1
259,Floxuridine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(CC1O)n1cc(F)c(=O)[nH]c1=O,5790.0,1
260,Tigecycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(Nc1cc(N(C)C)c2c(c1O)C(=C1C(C2)CC2C(C1=O)(O)C(=C(C(=O)C2N(C)C)C(=O)N)O)O)CNC(C)(C)C,54686904.0,1
261,Pemetrexed,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(=O)CCC(C(=O)O)NC(=O)c1ccc(cc1)CCc1c[nH]c2c1c(=O)[nH]c(n2)N,135410875.0,1
262,L(+)-Ascorbic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(C1OC(=O)C(=C1O)O)O,54670067.0,1
263,Glutathione,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N,124886.0,1
264,Hesperetin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COc1ccc(cc1O)C1CC(=O)c2c(O1)cc(cc2O)O,72281.0,1
265,Ademetionine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C[S+](CC1OC(C(C1O)O)n1cnc2c1ncnc2N)CCC(C(=O)[O-])N,34755.0,1
266,Masoprocol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C(Cc1ccc(c(c1)O)O)C)Cc1ccc(c(c1)O)O,71398.0,1
267,Isotretinoin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,5282379.0,1
268,Dantrolene,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C1CN(C(=O)N1)N=Cc1ccc(o1)c1ccc(cc1)[N+](=O)[O-],6914273.0,1
269,Sulfasalazine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(=O)c1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)ccc1O,5339.0,1
270,Silybin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1Oc2ccc(cc2OC1c1ccc(c(c1)OC)O)C1Oc2cc(O)cc(c2C(=O)C1O)O,31553.0,1
271,Nicardipine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C,4474.0,1
272,Sildenafil,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCc1nn(c2c1nc([nH]c2=O)c1cc(ccc1OCC)S(=O)(=O)N1CCN(CC1)C)C,135398744.0,1
273,Platycodin D,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1(CO)C(OC2OC(CO)C(C(C2O)O)O)C(O)CC2(C1CCC1(C2CC=C2C1(C)CC(O)C1(C2CC(CC1)(C)C)C(=O)OC1OCC(C(C1OC1OC(C)C(C(C1O)O)OC1OCC(C(C1O)OC1OCC(C1O)(O)CO)O)O)O)C)C,162859.0,1
274,Chrysin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Oc1cc(O)c2c(c1)oc(cc2=O)c1ccccc1,5281607.0,1
275,Neohesperidin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(Oc2cc3OC(CC(=O)c3c(c2)O)c2ccc(c(c2)O)OC)C(C(C1O)O)OC1OC(C)C(C(C1O)O)O,442439.0,1
276,Baicalin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(=O)C1OC(Oc2cc3oc(cc(=O)c3c(c2O)O)c2ccccc2)C(C(C1O)O)O,64982.0,1
277,(–)-Epigallocatechin gallate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C1OCC23C1c1ccccc1N3C(=O)c1c(N2)cccc1,,1
278,Phaitanthrin D,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C1OCC23C1c1ccccc1N3C(=O)c1c(N2)cccc1,24970703.0,1
279,Piceatannol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Oc1cc(C=Cc2ccc(c(c2)O)O)cc(c1)O,667639.0,1
280,Rosmarinic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(OC(C(=O)O)Cc1ccc(c(c1)O)O)C=Cc1ccc(c(c1)O)O,5281792.0,1
281,Magnolol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C=CCc1ccc(c(c1)c1cc(CC=C)ccc1O)O,72300.0,1
282,Lymecycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,NC(C(=O)O)CCCCNCNC(=O)C1=C(O)C2(C(C(C1=O)N(C)C)CC1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O,54707177.0,1
283,Chlorhexidine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,NC(=NCCCCCCN=C(N=C(Nc1ccc(cc1)Cl)N)N)N=C(Nc1ccc(cc1)Cl)N,9552079.0,1
284,Alfuzosin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COc1cc2nc(nc(c2cc1OC)N)N(CCCNC(=O)C1CCCO1)C,2092.0,1
285,Cilastatin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(=O)C(CSCCCCC=C(C(=O)O)NC(=O)C1CC1(C)C)N,6435415.0,1
286,Famotidine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,NC(=Nc1scc(n1)CSCCC(=NS(=O)(=O)N)N)N,5702160.0,1
287,Almitrine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C=CCNc1nc(nc(n1)NCC=C)N1CCN(CC1)C(c1ccc(cc1)F)c1ccc(cc1)F,33887.0,1
288,Progabide,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,NC(=O)CCCN=C(c1cc(F)ccc1O)c1ccc(cc1)Cl,44115.0,1
289,Nepafenac,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,NC(=O)Cc1cccc(c1N)C(=O)c1ccccc1,151075.0,1
290,Carvedilol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COc1ccccc1OCCNCC(COc1cccc2c1c1ccccc1[nH]2)O,2585.0,1
291,Amprenavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1CCOC1)O)C,65016.0,1
292,Tigecycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(Nc1cc(N(C)C)c2c(c1O)C(=C1C(C2)CC2C(C1=O)(O)C(=C(C(=O)C2N(C)C)C(=O)N)O)O)CNC(C)(C)C,54686904.0,1
293,Demeclocycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN(C1C(=O)C(=C(C2(C1CC1C(=C(O)c3c(C1O)c(Cl)ccc3O)C2=O)O)O)C(=O)N)C,54680690.0,1
294,Montelukast,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(=O)CC1(CSC(c2cccc(c2)C=Cc2ccc3c(n2)cc(cc3)Cl)CCc2ccccc2C(O)(C)C)CC1,5281040.0,1
295,Carminic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(C(C(C1O)O)O)c1c(O)c2c(c(c1O)O)C(=O)c1c(C2=O)c(C)c(c(c1)O)C(=O)O,10255083.0,1
296,Mimosine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(=O)C(Cn1ccc(=O)c(c1)O)N,3862.0,1
297,Flavin mononucleotide,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=c1[nH]c(=O)c2c(n1)n(CC(C(C(COP(=O)(O)O)O)O)O)c1c(n2)cc(c(c1)C)C,,1
298,Lutein,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=CC=CC=C(C=CC=C(C=CC1=C(C)CC(CC1(C)C)O)C)C)C=CC=C(C=CC1C(=CC(CC1(C)C)O)C)C,,1
299,Cefpiramide,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Oc1ccc(cc1)C(C(=O)NC1C(=O)N2C1SCC(=C2C(=O)O)CSc1nnnn1C)NC(=O)c1c[nH]c(cc1=O)C,5281243.0,1
300,Phenethicillin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C(=O)NC1C(=O)N2C1SC(C2C(=O)O)(C)C)Oc1ccccc1,636405.0,1
301,Candoxatril,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COCCOCC(C(=O)Oc1ccc2c(c1)CCC2)CC1(CCCC1)C(=O)NC1CCC(CC1)C(=O)O,272833.0,1
302,Nicardipine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC(=O)C1=C(C)NC(=C(C1c1cccc(c1)[N+](=O)[O-])C(=O)OCCN(Cc1ccccc1)C)C,5362417.0,1
303,Estradiol valerate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCCC(=O)OC1CCC2C1(C)CCC1C2CCc2c1ccc(c2)O,4474.0,1
304,Pioglitazone,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCc1ccc(nc1)CCOc1ccc(cc1)CC1SC(=O)NC1=O,13791.0,1
305,Conivaptan,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Cc1[nH]c2c(n1)c1ccccc1N(CC2)C(=O)c1ccc(cc1)NC(=O)c1ccccc1c1ccccc1,4829.0,1
306,Telmisartan,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2,151171.0,1
307,Doxycycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN(C1C(=O)C(=C(C2(C1C(O)C1C(C)c3cccc(c3C(=C1C2=O)O)O)O)O)C(=O)N)C,65999.0,1
308,Oxytetracycline,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN(C1C(=O)C(=C(C2(C1C(O)C1C(=C(O)c3c(C1(C)O)cccc3O)C2=O)O)O)C(=O)N)C,54671203.0,1
309,Valganciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(OCn1cnc2c1nc(N)[nH]c2=O)COC(=O)C(C(C)C)N,54675779.0,1
310,Chlorhexidine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,NC(=NCCCCCCN=C(N=C(Nc1ccc(cc1)Cl)N)N)N=C(Nc1ccc(cc1)Cl)N,135413535.0,1
311,Ceftibuten,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(=O)CC=C(C(=O)NC1C(=O)N2C1SCC=C2C(=O)O)c1csc(n1)N,9552079.0,1
312,Fenoterol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(Cc1ccc(cc1)O)NCC(c1cc(O)cc(c1)O)O,5282242.0,1
313,Fludarabine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(C(C1O)O)n1cnc2c1nc(F)nc2N,3343.0,1
314,Itraconazole,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCC(n1ncn(c1=O)c1ccc(cc1)N1CCN(CC1)c1ccc(cc1)OCC1COC(O1)(Cn1cncn1)c1ccc(cc1Cl)Cl)C,657237.0,1
315,Cefuroxime,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CON=C(C(=O)NC1C(=O)N2C1SCC(=C2C(=O)O)COC(=O)N)c1ccco1,3793.0,1
316,Atovaquone,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Clc1ccc(cc1)C1CCC(CC1)C1=C(O)c2c(C(=O)C1=O)cccc2,5479529.0,1
317,Chenodeoxycholic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC1CCC2(C(C1)CC(C1C2CCC2(C1CCC2C(CCC(=O)O)C)C)O)C,74989.0,1
318,Cromolyn,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(COc1cccc2c1c(=O)cc(o2)C(=O)O)COc1cccc2c1c(=O)cc(o2)C(=O)O,10133.0,1
319,Pancuronium bromide,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=O)OC1CC2CCC3C(C2(CC1[N+]1(C)CCCCC1)C)CCC1(C3CC(C1OC(=O)C)[N+]1(C)CCCCC1)C.[Br-].[Br-],2882.0,1
320,Cortisone,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(=O)C1(O)CCC2C1(C)CC(=O)C1C2CCC2=CC(=O)CCC12C,27350.0,1
321,Tibolone,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C#CC1(O)CCC2C1(C)CCC1C2C(C)CC2=C1CCC(=O)C2,222786.0,1
322,Novobiocin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC1C(OC(=O)N)C(O)C(OC1(C)C)Oc1ccc2c(c1C)oc(=O)c(c2O)NC(=O)c1ccc(c(c1)CC=C(C)C)O,444008.0,1
323,Silybin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1Oc2ccc(cc2OC1c1ccc(c(c1)OC)O)C1Oc2cc(O)cc(c2C(=O)C1O)O,54675769.0,1
324,Idarubicin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC1C(N)CC(OC1C)OC1CC(O)(Cc2c1c(O)c1c(c2O)C(=O)c2c(C1=O)cccc2)C(=O)C,31553.0,1
325,Bromocriptine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(CC1C(=O)N2CCCC2C2(N1C(=O)C(O2)(NC(=O)C1CN(C)C2C(=C1)c1cccc3c1c(C2)c([nH]3)Br)C(C)C)O)C,42890.0,1
326,Diphenoxylate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCOC(=O)C1(CCN(CC1)CCC(c1ccccc1)(c1ccccc1)C#N)c1ccccc1,31101.0,1
327,Benzylpenicilloyl G,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(NC(C1NC(C(S1)(C)C)C(=O)O)C(=O)NCCCCCC(=O)O)Cc1ccccc1,13505.0,1
328,Dabigatran etexilate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCCCCOC(=O)N=C(c1ccc(cc1)NCc1nc2c(n1C)ccc(c2)C(=O)N(c1ccccn1)CCC(=O)OCC)N,119212.0,1
329,Betulonal,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=CC12CCC(C2C2C(CC1)(C)C1(C)CCC3C(C1CC2)(C)CCC(=O)C3(C)C)C(=C)C,,1
330,Andrographiside,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(OCC2(C)C(O)CCC3(C2CCC(=C)C3CC=C2C(O)COC2=O)C)C(C(C1O)O)O,,1
331,Cerevisterol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC1CCC2(C(C1)(O)C(O)C=C1C2CCC2(C1CCC2C(C=CC(C(C)C)C)C)C)C,,1
332,Hesperidin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COc1ccc(cc1O)C1CC(=O)c2c(O1)cc(cc2O)OC1OC(COC2OC(C)C(C(C2O)O)O)C(C(C1O)O)O,10181133.0,1
333,Neohesperidin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(Oc2cc3OC(CC(=O)c3c(c2)O)c2ccc(c(c2)O)OC)C(C(C1O)O)OC1OC(C)C(C(C1O)O)O,10621.0,1
334,Andrograpanin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1(C)CCCC2(C1CCC(=C)C2CCC1=CCOC1=O)C,442439.0,1
335,Cosmosiin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(Oc2cc(O)c3c(c2)oc(cc3=O)c2ccc(cc2)O)C(C(C1O)O)O,,1
336,Biorobin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Oc1ccc(cc1)c1oc2cc(O)cc(c2c(=O)c1OC1OC(COC2OC(C)C(C(C2O)O)O)C(C(C1O)O)O)O,,1
337,Gnidicin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC12OC1C1C3OC4(OC1(C1C(C2O)(O)C(=O)C(=C1)C)C(C(C3(O4)C(=C)C)OC(=O)C=Cc1ccccc1)C)c1ccccc1,12313332.0,1
338,Rosmarinic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(OC(C(=O)O)Cc1ccc(c(c1)O)O)C=Cc1ccc(c(c1)O)O,,1
339,Oleanolic acid,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC1CCC2(C(C1(C)C)CCC1(C2CC=C2C1(C)CCC1(C2CC(C)(C)CC1)C(=O)O)C)C,,1
340,Stigmast-5-en-3-ol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCC(C(C)C)CCC(C1CCC2C1(C)CCC1C2CC=C2C1(C)CCC(C2)O)C,10494.0,1
341,Berchemol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COc1cc(ccc1O)CC1COC(C1(O)CO)c1ccc(c(c1)OC)O,,1
342,Betulonal,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=CC12CCC(C2C2C(CC1)(C)C1(C)CCC3C(C1CC2)(C)CCC(=O)C3(C)C)C(=C)C,14521044.0,1
343,Gnidicin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC12OC1C1C3OC4(OC1(C1C(C2O)(O)C(=O)C(=C1)C)C(C(C3(O4)C(=C)C)OC(=O)C=Cc1ccccc1)C)c1ccccc1,473111.0,1
344,Gniditrin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCC=CC=CC=CC(=O)OC1C(C)C23OC4(OC1(C(=C)C)C(C2C1OC1(C(C1(C3C=C(C1=O)C)O)O)CO)O4)c1ccccc1,,1
345,"Theaflavin 3,3′-di-O-gallate",SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Oc1cc2OC(C(Cc2c(c1)O)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(=O)c2c(c1)c(cc(c2O)O)C1Oc2cc(O)cc(c2CC1OC(=O)c1cc(O)c(c(c1)O)O)O,,1
346,Phyllaemblicin B,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(OC(=O)C2CC(O)C3(C(C2)OC2(C3=O)OCC(C(C2)OC(=O)c2ccccc2)C)O)C(C(C1O)O)OC1OC(CO)C(C(C1O)O)O,,1
347,Andrographiside,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(OCC2(C)C(O)CCC3(C2CCC(=C)C3CC=C2C(O)COC2=O)C)C(C(C1O)O)O,,1
348,Baicalin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(=O)C1OC(Oc2cc3oc(cc(=O)c3c(c2O)O)c2ccccc2)C(C(C1O)O)O,44593583.0,1
349,"1,7-Dihydroxy-3-methoxyxanthone",SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COc1cc(O)c2c(c1)oc1c(c2=O)cc(cc1)O,,1
350,Emtricitabine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Nc1nc(=O)n(cc1F)C1CSC(O1)CO,,1
351,Tenofovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(Cn1cnc2c1ncnc2N)OCP(=O)(O)O,,1
352,Efavirenz,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,FC(C1(C#CC2CC2)OC(=O)Nc2c1cc(Cl)cc2)(F)F,,1
353,Nevirapine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Cc1ccnc2c1[nH]c(=O)c1c(n2C2CC2)nccc1,60877.0,1
354,Saquinavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,464205.0,1
355,Indinavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(CN1CCN(CC1C(=O)NC(C)(C)C)Cc1cccnc1)CC(C(=O)NC1C(O)Cc2c1cccc2)Cc1ccccc1,64139.0,1
356,Nelfinavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(C(NC(=O)c1cccc(c1C)O)CSc1ccccc1)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,4463.0,1
357,Atazanavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,441243.0,1
358,Tipranavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCC1(CCc2ccccc2)CC(=C(C(=O)O1)C(c1cccc(c1)NS(=O)(=O)c1ccc(cn1)C(F)(F)F)CC)O,5362440.0,1
359,Abacavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1C=CC(C1)n1cnc2c1nc(N)nc2NC1CC1,64143.0,1
360,Doravirine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,N#Cc1cc(cc(c1)Cl)Oc1c(=O)n(ccc1C(F)(F)F)Cc1n[nH]c(=O)n1C,148192.0,1
361,Etravirine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,N#Cc1ccc(cc1)Nc1nc(N)c(c(n1)Oc1c(C)cc(cc1C)C#N)Br,54682461.0,1
362,Rilpivirine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,N#CC=Cc1cc(C)c(c(c1)C)Nc1ccnc(n1)Nc1ccc(cc1)C#N,441300.0,1
363,Dolutegravir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Fc1ccc(c(c1)F)CNC(=O)c1cn2CC3OCCC(N3C(=O)c2c(c1=O)O)C,58460047.0,1
364,Raltegravir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Fc1ccc(cc1)CNC(=O)c1nc(n(c(=O)c1O)C)C(NC(=O)c1nnc(o1)C)(C)C,193962.0,1
365,Penciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO,6451164.0,1
366,Cytarabine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(C(C1O)O)n1ccc(nc1=O)N,54726191.0,1
367,Cidofovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(Cn1ccc(nc1=O)N)OCP(=O)(O)O,54671008.0,1
368,Tromantadine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CN(CCOCC(=O)NC12CC3CC(C2)CC(C1)C3)C,135398748.0,1
369,Imiquimod,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(Cn1cnc2c1c1ccccc1nc2N)C,6253.0,1
370,Podophyllotoxin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COc1cc(cc(c1OC)OC)C1C2C(=O)OCC2C(c2c1cc1OCOc1c2)O,60613.0,1
371,Adefovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,64377.0,1
372,Clevudine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(C(C1O)F)n1cc(C)c(=O)[nH]c1=O,57469.0,1
373,Telbivudine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(CC1O)n1cc(C)c(=O)[nH]c1=O,10607.0,1
374,Ribavirin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,60172.0,1
375,Boceprevir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(NC(C)(C)C)NC(C(C)(C)C)C(=O)N1CC2C(C1C(=O)NC(C(=O)C(=O)N)CC1CCC1)C2(C)C,73115.0,1
376,Telaprevir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C1C2CCCC2CN1C(=O)C(C(C)(C)C)NC(=O)C(C1CCCCC1)NC(=O)c1nccnc1,159269.0,1
377,Arbidol,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,37542.0,1
378,Inosine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1OC(C(C1O)O)n1cnc2c1nc[nH]c2=O,10324367.0,1
379,Rimantadine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C12CC3CC(C2)CC(C1)C3)N,3010818.0,1
380,Amantadine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,NC12CC3CC(C2)CC(C1)C3,131411.0,1
381,Maraviroc,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(C1CCC(CC1)(F)F)NC(c1ccccc1)CCN1C2CCC1CC(C2)n1c(C)nnc1C(C)C,135398641.0,1
382,Zanamivir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(C(C1OC(=CC(C1NC(=O)C)N=C(N)N)C(=O)O)O)O,5071.0,1
383,Acyclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCCOCn1cnc2c1nc(N)[nH]c2=O,2130.0,1
384,Ganciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(OCn1cnc2c1nc(N)[nH]c2=O)CO,3002977.0,1
385,Valganciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(OCn1cnc2c1nc(N)[nH]c2=O)COC(=O)C(C(C)C)N,60855.0,1
386,Valaciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(C(C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O)N)C,135398513.0,1
387,Suramin,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)Nc1cccc(c1)C(=O)Nc1cc(ccc1C)C(=O)Nc1ccc(c2c1c(cc(c2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,135398740.0,1
388,"DHPA (S)-9-(2,3-Dihydroxypropyl)adenine",SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(Cn1cnc2c1ncnc2N)O,135413535.0,1
389,BVDU Brivudine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Br/C=C/c1cn([C@H]2C[C@@H]([C@H](O2)CO)O)c(=O)nc1O,135398742.0,1
390,ACV triphosphate Acycloguanosine triphosphate,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Nc1[nH]c(=O)c2c(n1)n(COCCOP(=O)(OP(=O)(OP(=O)(O)O)O)O)cn2,,1
391,(S)-HPMPA (S)-9-(3-hydroxy-2-phosphonomethoxypropyl)adenine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(Cn1cnc2c1ncnc2N)OCP(=O)(O)O,,1
392,STAVUDINE,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Cc1cn(C2OC(C=C2)CO)c(=O)[nH]c1=O,,1
393,Didanosine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1CCC(O1)n1cnc2c1nc[nH]c2=O,,1
394,Zalcitabine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Nc1ccn(c(=O)n1)C1CCC(O1)CO,,1
395,Pyrimidinedione,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=c1cc[nH]c(=O)[nH]1,,1
396,Emivirine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCOCn1c(=O)[nH]c(=O)c(c1Cc1ccccc1)C(C)C,,1
397,Delavirdine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(Nc1cccnc1N1CCN(CC1)C(=O)c1cc2c([nH]1)ccc(c2)NS(=O)(=O)C)C,,1
398,Dapivirine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,N#Cc1ccc(cc1)Nc1nccc(n1)Nc1c(C)cc(cc1C)C,,1
399,TIBO,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=CCN1Cc2cccc3c2n(CC1C)c(=S)[nH]3)C,,1
400,Tivirapine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=CCN1Cc2c(Cl)ccc3c2n(CC1C)c(=S)[nH]3)C,,1
401,Elvitegravir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC(n1cc(C(=O)O)c(=O)c2c1cc(OC)c(c2)Cc1cccc(c1F)Cl)C(C)C,,1
402,Cobicistat,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(NC(Cc1ccccc1)CCC(Cc1ccccc1)NC(=O)C(NC(=O)N(Cc1csc(n1)C(C)C)C)CCN1CCOCC1)OCc1cncs1,18283.0,1
403,Plerixafor,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,C1CNCCN(CCCNCCNC1)Cc1ccc(cc1)CN1CCNCCCNCCNCCC1,135398739.0,1
404,Bictegravir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Fc1cc(F)c(c(c1)F)CNC(=O)c1cn2CC3OC4CCC(N3C(=O)c2c(c1=O)O)C4,24066.0,1
405,Rabacfosadine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCOC(=O)C(NP(=O)(NC(C(=O)OCC)C)COCCn1cnc2c1nc(N)nc2NC1CC1)C,,1
406,FV 100 Valnivudine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CCCCCc1ccc(cc1)c1oc2c(c1)cn(c(=O)n2)C1CC(C(O1)COC(=O)C(C(C)C)N)O,65013.0,1
407,GS 9191,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(COC(=O)C(NP(=O)(NC(C(=O)OCC(C)C)Cc1ccccc1)COCCn1cnc2c1nc(N)nc2NC1CC1)Cc1ccccc1)C,5625.0,1
408,PMEO-DAPy,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Nc1cc(OCCOCP(=O)(O)O)nc(n1)N,3000236.0,1
409,Ritonavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,5277135.0,1
410,Lopinavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,25151504.0,1
411,Darunavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,65015.0,1
412,Favipiravir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Fc1c[nH]c(=O)c(n1)C(=O)N,90311989.0,1
413,Famciclovir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,CC(=O)OCC(CCn1cnc2c1nc(N)nc2)COC(=O)C,16047979.0,1
414,Foscarnet,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OC(=O)P(=O)(O)O,,1
415,Lamivudine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,Nc1ccn(c(=O)n1)C1CSC(O1)CO,,1
416,Emtricitabine,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1SC(C(O1)n1cc(F)c(nc1=O)N)[F]c1cn([C@@H]2CS[C@@H](O2)CO)c(nc1=N)O,,1
417,Entecavir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,OCC1C(O)CC(C1=C)n1cnc2c1nc(N)[nH]c2=O,,1
418,Beclabuvir,SARS-CoV-2,10.1016/j.apsb.2020.02.008,computational,COc1ccc2c(c1)C1CC1(Cn1c2c(C2CCCCC2)c2c1cc(cc2)C(=O)NS(=O)(=O)N(C)C)C(=O)N1C2CCC1CN(C2)C,,1
419,dec-RVKR-CMK,MERS,nrd.2015.37,experimental,NCCCCC(C(=O)NC(C(=O)CCl)CCCN=C(N)N)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CCCCCCCCC)CCCN=C(N)N,,1
420,β-D-N4-hydroxycytidine,SARS-COV-2,10.1101/2020.03.19.997890,experimental,OCC1OC(C(C1O)O)n1ccc(nc1=O)NO,,1
421,dichlorobenzyl alcohol,SARS-COV-2,10.1177/095632020501600205,experimental,OCc1cc(Cl)cc(c1)Cl,,1
422,Amylmetacresol,SARS-COV-2,10.1177/095632020501600205,experimental,CCCCCc1ccc(cc1O)C,,1
423,oseltamivir,Mixed,Kaggle,mixed,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028.0,1
424,abacavir,Mixed,Kaggle,mixed,OCC1C=CC(C1)n1cnc2c1nc(N)nc2NC1CC1,441300.0,1
425,acyclovir,Mixed,Kaggle,mixed,OCCOCn1cnc2c1nc(N)[nH]c2=O,135398513.0,1
426,adefovir,Mixed,Kaggle,mixed,Nc1ncnc2c1ncn2CCOCP(=O)(O)O,60172.0,1
427,alisporivir,Mixed,Kaggle,mixed,CC=CCC(C(C1C(=O)NC(CC)C(=O)N(C)C(C)C(=O)N(CC)C(C(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C,11513676.0,1
428,amdoxovir,Mixed,Kaggle,mixed,OCC1OCC(O1)n1cnc2c1nc(N)nc2N,124088.0,1
429,amprenavir,Mixed,Kaggle,mixed,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1CCOC1)O)C,65016.0,1
430,atazanavir,Mixed,Kaggle,mixed,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192.0,1
431,balapiravir,Mixed,Kaggle,mixed,[N-]=[N+]=NC1(COC(=O)C(C)C)OC(C(C1OC(=O)C(C)C)OC(=O)C(C)C)n1ccc(nc1=O)N,11691726.0,1
432,baloxavir,Mixed,Kaggle,mixed,Fc1c(F)ccc2c1CSc1c(C2N2C3COCCN3C(=O)c3n2ccc(=O)c3O)cccc1,124081876.0,1
433,beclabuvir,Mixed,Kaggle,mixed,COc1ccc2c(c1)C1CC1(Cn1c2c(C2CCCCC2)c2c1cc(cc2)C(=O)NS(=O)(=O)N(C)C)C(=O)N1C2CCC1CN(C2)C,49773361.0,1
434,boceprevir,Mixed,Kaggle,mixed,O=C(NC(C)(C)C)NC(C(C)(C)C)C(=O)N1CC2C(C1C(=O)NC(C(=O)C(=O)N)CC1CCC1)C2(C)C,10324367.0,1
435,brincidofovir,Mixed,Kaggle,mixed,CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(Cn1ccc(nc1=O)N)CO)O,483477.0,1
436,carbovir,Mixed,Kaggle,mixed,OCC1C=CC(C1)n1cnc2c1nc(N)[nH]c2=O,135403630.0,1
437,celgosivir,Mixed,Kaggle,mixed,CCCC(=O)OC1CN2CCC(C2C(C1O)O)O,60734.0,1
438,cidofovir,Mixed,Kaggle,mixed,OCC(Cn1ccc(nc1=O)N)OCP(=O)(O)O,60613.0,1
439,combivir,Mixed,Kaggle,mixed,[N-]=[N+]=NC1CC(OC1COP(=O)(OP(=O)(OP(=O)(O)O)O)O)n1cc(C)c(=O)[nH]c1=O,72187.0,1
440,daclatasvir,Mixed,Kaggle,mixed,COC(=O)NC(C(=O)N1CCCC1c1ncc([nH]1)c1ccc(cc1)c1ccc(cc1)c1cnc([nH]1)C1CCCN1C(=O)C(C(C)C)NC(=O)OC)C(C)C,25154714.0,1
441,danoprevir,Mixed,Kaggle,mixed,O=C(OC(C)(C)C)NC1CCCCCC=CC2C(NC(=O)C3N(C1=O)CC(C3)OC(=O)N1Cc3c(C1)cccc3F)(C2)C(=O)NS(=O)(=O)C1CC1,11285588.0,1
442,darunavir,Mixed,Kaggle,mixed,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,213039.0,1
443,dasabuvir,Mixed,Kaggle,mixed,COc1c(cc(cc1C(C)(C)C)n1ccc(=O)[nH]c1=O)c1ccc2c(c1)ccc(c2)NS(=O)(=O)C,56640146.0,1
444,dolutegravir,Mixed,Kaggle,mixed,Fc1ccc(c(c1)F)CNC(=O)c1cn2CC3OCCC(N3C(=O)c2c(c1=O)O)C,54726191.0,1
445,elbasvir,Mixed,Kaggle,mixed,COC(=O)NC(C(=O)N1CCCC1c1ncc([nH]1)c1ccc2c(c1)OC(n1c2cc2c1ccc(c2)c1cnc([nH]1)C1CCCN1C(=O)C(C(C)C)NC(=O)OC)c1ccccc1)C(C)C,71661251.0,1
446,elvitegravir,Mixed,Kaggle,mixed,OCC(n1cc(C(=O)O)c(=O)c2c1cc(OC)c(c2)Cc1cccc(c1F)Cl)C(C)C,5277135.0,1
447,entecavir,Mixed,Kaggle,mixed,OCC1C(O)CC(C1=C)n1cnc2c1nc(N)[nH]c2=O,135398508.0,1
448,famciclovir,Mixed,Kaggle,mixed,CC(=O)OCC(CCn1cnc2c1nc(N)nc2)COC(=O)C,3324.0,1
449,famvir,Mixed,Kaggle,mixed,CC(=O)OCC(CCn1cnc2c1nc(N)nc2)COC(=O)C,3324.0,1
450,favipiravir,Mixed,Kaggle,mixed,Fc1c[nH]c(=O)c(n1)C(=O)N,492405.0,1
451,fosamprenavir,Mixed,Kaggle,mixed,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1CCOC1)OP(=O)(O)O)C,131536.0,1
452,galidesivir,Mixed,Kaggle,mixed,OCC1NC(C(C1O)O)c1c[nH]c2c1ncnc2N,10445549.0,1
453,ganciclovir,Mixed,Kaggle,mixed,OCC(OCn1cnc2c1nc(N)[nH]c2=O)CO,135398740.0,1
454,glecaprevir,Mixed,Kaggle,mixed,O=C1OC2CCCC2OCC=CC(F)(F)c2c(OC3CN(C(=O)C(N1)C(C)(C)C)C(C3)C(=O)NC1(CC1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1)nc1c(n2)cccc1,66828839.0,1
455,grazoprevir,Mixed,Kaggle,mixed,C=CC1CC1(NC(=O)C1CC2CN1C(=O)C(NC(=O)OC1CC1CCCCCc1c(O2)nc2cc(OC)ccc2n1)C(C)(C)C)C(=O)NS(=O)(=O)C1CC1,44603531.0,1
456,laninamivir,Mixed,Kaggle,mixed,OCC(C(C1OC(=CC(C1NC(=O)C)N=C(N)N)C(=O)O)OC)O,502272.0,1
457,ledipasvir,Mixed,Kaggle,mixed,COC(=O)NC(C(=O)N1CC2(CC1c1ncc([nH]1)c1ccc3c(c1)C(F)(F)c1c3ccc(c1)c1ccc3c(c1)[nH]c(n3)C1C3CCC(N1C(=O)C(C(C)C)NC(=O)OC)C3)CC2)C(C)C,67505836.0,1
458,letermovir,Mixed,Kaggle,mixed,COc1cccc(c1)N1CCN(CC1)C1=Nc2c(F)cccc2C(N1c1cc(ccc1OC)C(F)(F)F)CC(=O)O,45138674.0,1
459,lobucavir,Mixed,Kaggle,mixed,OCC1C(CO)CC1n1cnc2c1nc(N)[nH]c2=O,135413519.0,1
460,lopinavir,Mixed,Kaggle,mixed,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,1
461,maribavir,Mixed,Kaggle,mixed,OCC1OC(C(C1O)O)n1c(NC(C)C)nc2c1cc(Cl)c(c2)Cl,471161.0,1
462,nelfinavir,Mixed,Kaggle,mixed,OC(C(NC(=O)c1cccc(c1C)O)CSc1ccccc1)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,64143.0,1
463,ombitasvir,Mixed,Kaggle,mixed,COC(=O)NC(C(=O)N1CCCC1C(=O)Nc1ccc(cc1)C1CCC(N1c1ccc(cc1)C(C)(C)C)c1ccc(cc1)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)OC)C(C)C,54767916.0,1
464,oseltamivir,Mixed,Kaggle,mixed,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028.0,1
465,paritaprevir,Mixed,Kaggle,mixed,Cc1ncc(nc1)C(=O)NC1CCCCCC=CC2C(NC(=O)C3N(C1=O)CC(C3)Oc1nc3ccccc3c3c1cccc3)(C2)C(=O)NS(=O)(=O)C1CC1,45110509.0,1
466,penciclovir,Mixed,Kaggle,mixed,OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO,135398748.0,1
467,pencyclovir,Mixed,Kaggle,mixed,OCC(CCn1cnc2c1nc(N)[nH]c2=O)CO,135398748.0,1
468,peramivir,Mixed,Kaggle,mixed,CCC(C(C1C(N=C(N)N)CC(C1O)C(=O)O)NC(=O)C)CC,154234.0,1
469,pibrentasvir,Mixed,Kaggle,mixed,COC(=O)NC(C(=O)N1CCCC1c1[nH]c2c(n1)cc(c(c2)C1CCC(N1c1cc(F)c(c(c1)F)N1CCC(CC1)c1ccc(cc1)F)c1cc2[nH]c(nc2cc1F)C1CCCN1C(=O)C(C(OC)C)NC(=O)OC)F)C(OC)C,58031952.0,1
470,pimodivir,Mixed,Kaggle,mixed,OC(=O)C1C2CCC(C1Nc1nc(ncc1F)c1c[nH]c3c1cc(F)cn3)CC2,67286591.0,1
471,pirodavir,Mixed,Kaggle,mixed,CCOC(=O)c1ccc(cc1)OCCC1CCN(CC1)c1ccc(nn1)C,71345.0,1
472,pocapavir,Mixed,Kaggle,mixed,COc1ccc(c(c1)Cl)OCc1ccc(cc1)COc1c(Cl)cccc1Cl,1455.0,1
473,presatovir,Mixed,Kaggle,mixed,NC1CCN(C1)c1nc2cc(nn2cc1C)C1CCCCN1C(=O)c1cc(Cl)ccc1NS(=O)(=O)C,58029842.0,1
474,raltegravir,Mixed,Kaggle,mixed,Fc1ccc(cc1)CNC(=O)c1nc(n(c(=O)c1O)C)C(NC(=O)c1nnc(o1)C)(C)C,54671008.0,1
475,remdesivir,Mixed,Kaggle,mixed,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016.0,1
476,ritonavir,Mixed,Kaggle,mixed,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,1
477,rupintrivir,Mixed,Kaggle,mixed,CCOC(=O)C=CC(CC1CCNC1=O)NC(=O)C(Cc1ccc(cc1)F)CC(=O)C(C(C)C)NC(=O)c1noc(c1)C,6440352.0,1
478,saquinavir,Mixed,Kaggle,mixed,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243.0,1
479,simeprevir,Mixed,Kaggle,mixed,COc1ccc2c(c1C)nc(cc2OC1CC2C(C1)C(=O)N(C)CCCCC=CC1C(NC2=O)(C1)C(=O)NS(=O)(=O)C1CC1)c1scc(n1)C(C)C,24873435.0,1
480,sofosbuvir,Mixed,Kaggle,mixed,CC(OC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)(C)F)n1ccc(=O)[nH]c1=O)C)C,45375808.0,1
481,telaprevir,Mixed,Kaggle,mixed,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C1C2CCCC2CN1C(=O)C(C(C)(C)C)NC(=O)C(C1CCCCC1)NC(=O)c1nccnc1,3010818.0,1
482,tenofovir,Mixed,Kaggle,mixed,CC(Cn1cnc2c1ncnc2N)OCP(=O)(O)O,464205.0,1
483,tipranavir,Mixed,Kaggle,mixed,CCCC1(CCc2ccccc2)CC(=C(C(=O)O1)C(c1cccc(c1)NS(=O)(=O)c1ccc(cn1)C(F)(F)F)CC)O,54682461.0,1
484,umifenovir,Mixed,Kaggle,mixed,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411.0,1
485,valacyclovir,Mixed,Kaggle,mixed,CC(C(C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O)N)C,135398742.0,1
486,valganciclovir,Mixed,Kaggle,mixed,OCC(OCn1cnc2c1nc(N)[nH]c2=O)COC(=O)C(C(C)C)N,135413535.0,1
487,vapendavir,Mixed,Kaggle,mixed,CCOc1noc2c1ccc(c2)OCCC1CCN(CC1)c1ccc(nn1)C,504457.0,1
488,velpatasvir,Mixed,Kaggle,mixed,COCC1CC(N(C1)C(=O)C(c1ccccc1)NC(=O)OC)c1ncc([nH]1)c1ccc2c(c1)COc1c2cc2ccc3c(c2c1)nc([nH]3)C1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C,67683363.0,1
489,voxilaprevir,Mixed,Kaggle,mixed,CCC1C2CN(C1C(=O)NC1(CC1C(F)F)C(=O)NS(=O)(=O)C1(C)CC1)C(=O)C(NC(=O)OC1CC1CCCCC(c1c(O2)nc2cc(OC)ccc2n1)(F)F)C(C)(C)C,89921642.0,1
490,zanamivir,Mixed,Kaggle,mixed,OCC(C(C1OC(=CC(C1NC(=O)C)N=C(N)N)C(=O)O)O)O,60855.0,1
491,zintevir,Mixed,Kaggle,mixed,OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=O)(OCC1OC(CC1OP(=S)(OCC1OC(CC1O)n1cc(C)c(=O)[nH]c1=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cc(C)c(=O)[nH]c1=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cc(C)c(=O)[nH]c1=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cc(C)c(=O)[nH]c1=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cnc2c1nc(N)[nH]c2=O)O)n1cc(C)c(=O)[nH]c1=O)S)n1cnc2c1nc(N)[nH]c2=O,16130283.0,1
492,ziresovir,Mixed,Kaggle,mixed,Cc1ccc2c(c1)c(NCC1(N)COC1)nc(n2)N1CCS(=O)(=O)c2c(C1)cccc2,71262247.0,1
493,prulifloxacin,SARS-COV-2,10.1101/2020.01.28.922922,experimental,O=c1oc(c(o1)CN1CCN(CC1)c1cc2c(cc1F)c(=O)c(c1n2C(C)S1)C(=O)O)C,65947.0,1
494,tegobuvir,SARS-COV-2,10.1101/2020.01.28.922922,experimental,Fc1ccccc1c1nc2c(n1)cn(cc2)Cc1ccc(nn1)c1ccc(cc1C(F)(F)F)C(F)(F)F,23649154.0,1
495,bictegravir,SARS-COV-2,10.1101/2020.01.28.922922,experimental,Fc1cc(F)c(c(c1)F)CNC(=O)c1cn2CC3OC4CCC(N3C(=O)c2c(c1=O)O)C4,90311989.0,1
496,nelfinavir,SARS-COV-2,10.1101/2020.01.28.922922,experimental,OC(C(NC(=O)c1cccc(c1C)O)CSc1ccccc1)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,64143.0,1
497,Lopinavir,SARS-COV-2,,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,0
498,ritonavir,SARS-COV-2,,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,0
499,favipiravir,SARS-COV-2,,experimental,Fc1c[nH]c(=O)c(n1)C(=O)N,492405.0,0
500,ribavirin,SARS-COV-2,,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,0
501,monophosphoramidate,SARS-COV-2,,experimental,O[C@@H]1[C@H](O)[C@H](O[C@H]1n1cnc2c1ncnc2N)COP(=O)(N)[O-].[Na+],,0
502,remdesivir,SARS-COV-2,,experimental,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016.0,0
503,ASC09 (TMC-310911),SARS-COV-2,,experimental,CC(CN(S(=O)(=O)c1ccc2c(c1)sc(n2)NC1CCN(CC1)C1CCCC1)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,,0
504,arbidol,SARS-COV-2,,experimental,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411.0,0
505,Chlorpromazine hydrochloride,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C.Cl,6240.0,0
506,ribavirin,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,0
507,mycophenolic acid,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,COc1c(CC=C(CCC(=O)O)C)c(O)c2c(c1C)COC2=O,446541.0,0
508,Disulfiram,SARS-COV-2,https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates,experimental,CCN(C(=S)SSC(=S)N(CC)CC)CC,3117.0,0
509,Nitazoxonide,SARS-COV-2,https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates,experimental,CC(=O)Oc1ccccc1C(=O)Nc1ncc(s1)[N+](=O)[O-],,0
510,Niclosamide,SARS-COV-2,https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates,experimental,Clc1ccc(c(c1)C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])O,4477.0,0
511,ciclesonide,SARS-COV-2,https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates,experimental,O=C(C(C)C)OCC(=O)C12OC(OC1CC1C2(C)CC(O)C2C1CCC1=CC(=O)C=CC21C)C1CCCCC1,6918155.0,0
512,quercetin,SARS-COV-2,https://blogs.sciencemag.org/pipeline/archives/2020/03/27/known-drugs-against-the-coronovirus-runner-up-candidates,experimental,Oc1cc(O)c2c(c1)oc(c(c2=O)O)c1ccc(c(c1)O)O,5280343.0,0
513,tetra-O-galloyl-D-glucose (TGG),SARS-COV-2,10.1128/JVI.78.20.11334–11339.2004,experimental,OC1C(OC(C(C1OC(=O)c1cc(O)c(c(c1)O)O)OC(=O)c1cc(O)c(c(c1)O)O)COC(=O)c1cc(O)c(c(c1)O)O)OC(=O)c1cc(O)c(c(c1)O)O,,0
514,luteolin,SARS-COV-2,10.1128/JVI.78.20.11334–11339.2004,experimental,Oc1cc(O)c2c(c1)oc(cc2=O)c1ccc(c(c1)O)O,5280445.0,0
515,Scutellarein,SARS,10.7150/ijbs.45538,experimental,Oc1ccc(cc1)c1cc(=O)c2c(o1)cc(c(c2O)O)O,5281697.0,0
516,Glycyrrhizin,SARS,10.7150/ijbs.45538,experimental,OC1C(OC2OC(C(=O)O)C(C(C2O)O)O)C(OC(C1O)C(=O)O)OC1CCC2(C(C1(C)C)CCC1(C2C(=O)C=C2C1(C)CCC1(C2CC(C)(CC1)C(=O)O)C)C)C,14982.0,0
517,Herbacetin,MERS,10.7150/ijbs.45538,experimental,Oc1ccc(cc1)c1oc2c(O)c(O)cc(c2c(=O)c1O)O,5280544.0,0
518,helichrysetin,MERS,10.7150/ijbs.45538,experimental,COc1cc(O)cc(c1C(=O)C=Cc1ccc(cc1)O)O,6253344.0,0
519,Tetrandrine,SARS,10.7150/ijbs.45538,experimental,COc1c(OC)cc2c3c1Oc1cc4c(cc1OC)CCN(C4Cc1ccc(Oc4cc(CC3N(CC2)C)ccc4OC)cc1)C,73078.0,0
520,fangchinoline,SARS,10.7150/ijbs.45538,experimental,COc1cc2CCN(C3c2c(c1O)Oc1cc2c(cc1OC)CCN(C2Cc1ccc(Oc2cc(C3)ccc2OC)cc1)C)C,73481.0,0
521,cepharanthine,SARS,10.7150/ijbs.45538,experimental,COc1cc2CCN(C3c2cc1Oc1c2c(CCN(C2Cc2ccc(Oc4cc(C3)ccc4OC)cc2)C)cc2c1OCO2)C,10206.0,0
522,pectolinarin,SARS,10.7150/ijbs.45538,experimental,COc1c(OC2OC(COC3OC(C)C(C(C3O)O)O)C(C(C2O)O)O)cc2c(c1O)c(=O)cc(o2)c1ccc(cc1)OC,168849.0,0
523,epigallocatechin gallate,SARS,10.7150/ijbs.45538,experimental,Oc1cc(O)c2c(c1)OC(C(C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O,65064.0,0
524,gallocatechin gallate,SARS,10.7150/ijbs.45538,experimental,Oc1cc(O)c2c(c1)OC(C(C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O,199472.0,0
525,Emodin,SARS,10.7150/ijbs.45538,experimental,Cc1cc(O)c2c(c1)C(=O)c1c(C2=O)c(O)cc(c1)O,3220.0,0
526,Baicalin,SARS,10.7150/ijbs.45538,experimental,OC(=O)C1OC(Oc2cc3oc(cc(=O)c3c(c2O)O)c2ccccc2)C(C(C1O)O)O,64982.0,0
527,Imatinib mesylate,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CS(=O)(=O)O.CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(c(c1)Nc1nccc(n1)c1cccnc1)C,123596.0,0
528,gemcitabine hydrochloride,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,OCC1OC(C(C1O)(F)F)n1ccc(nc1=O)N.Cl,60749.0,0
529,toremifene citrate,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,OC(=O)C(CC(=O)O)(CC(=O)O)O.ClCCC(=C(c1ccccc1)c1ccc(cc1)OCCN(C)C)c1ccccc1,3005572.0,0
530,Triflupromazine hydrochloride,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CN(CCCN1c2ccccc2Sc2c1cc(cc2)C(F)(F)F)C.Cl,66069.0,0
531,Dasatinib,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,OCCN1CCN(CC1)c1cc(nc(n1)C)Nc1ncc(s1)C(=O)Nc1c(C)cccc1Cl,3062316.0,0
532,Dimethyl sulfoxide,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CS(=O)C,679.0,0
533,Toremifene citrate,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,OC(=O)C(CC(=O)O)(CC(=O)O)O.ClCCC(=C(c1ccccc1)c1ccc(cc1)OCCN(C)C)c1ccccc1,3005572.0,0
534,chloroquine,MERS-CoV/SARS-CoV,10.1128/AAC.03036-14,experimental,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719.0,0
535,Lasinavir,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032712,computational,COCCNC(=O)C(C(C)C)NC(=O)C(Cc1ccc(c(c1OC)OC)OC)CC(C(Cc1ccccc1)NC(=O)OC(C)(C)C)O,464372.0,0
536,Brecanavir,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032712,computational,CC(CN(S(=O)(=O)c1ccc2c(c1)OCO2)CC(C(Cc1ccc(cc1)OCc1csc(n1)C)NC(=O)OC1COC2C1CCO2)O)C,5743186.0,0
537,Telinavir,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032713,computational,CC(CN(C(=O)NC(C)(C)C)CC(C(NC(=O)C(NC(=O)c1ccc2c(n1)cccc2)CC(=O)N)Cc1ccccc1)O)C,382974.0,0
538,Rotigaptide,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032714,computational,OC1CC(N(C1)C(=O)C1CCCN1C(=O)C(Cc1ccc(cc1)O)NC(=O)C)C(=O)NCC(=O)NC(C(=O)NCC(=O)N)C,9938933.0,0
539,Pimelautide,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032715,computational,CCCCCCCCCCCC(=O)NC(C(=O)NC(C(=O)O)CCC(=O)NC(C(=O)O)CCCC(C(=O)N)NC(=O)CN)C,70697634.0,0
540,"1,3-Bis-(2-ethoxycarbonylchromon-5-yloxy)-2-(lysyloxy)propane",SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032716,computational,NCCCCC(C(=O)OC(COc1cccc2c1c(=O)cc(o2)C(=O)OCC)COc1cccc2c1c(=O)cc(o2)C(=O)OCC)N.Cl.Cl,196638.0,0
541,Ociltide,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032717,computational,O=CNCCCCC(C(=O)NCC(=O)NC(C(=O)NC1CCSC1=O)Cc1ccccc1)NC(=O)C(Cc1ccc(cc1)O)N,76965368.0,0
542,Arzoxifene,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032718,computational,COc1ccc(cc1)c1sc2c(c1Oc1ccc(cc1)OCCN1CCCCC1)ccc(c2)O,179337.0,0
543,Tertamyloxycarbonyltetragastrin,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032719,computational,,,0
544,Truxicurium,SARS-COV-2,https://chemrxiv.org/articles/Screening_of_Clinically_Approved_and_Investigation_Drugs_as_Potential_Inhibitors_of_COVID-19_Main_Protease_A_Virtual_Drug_Repurposing_Study/12032720,computational,CC[N+](CCCOC(=O)C1C(c2ccccc2)C(C1c1ccccc1)C(=O)OCCC[N+](CC)(CC)C)(CC)C,20290.0,0
545,Ivermectin,SARS-COV-2,10.1016/j.antiviral.2020.104787,experimental,COC1CC(OC2C(C)C=CC=C3COC4C3(O)C(C=C(C4O)C)C(=O)OC3CC(CC=C2C)OC2(C3)CCC(C(O2)C(CC)C)C)OC(C1OC1CC(OC)C(C(O1)C)O)C,6321424.0,0
546,Oseltamivir,SARS-COV-2,https://doi.org/10.1101/2020.03.09.20033068,experimental,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028.0,0
547,Ribavirin,SARS-COV-2,https://doi.org/10.1101/2020.03.09.20033068,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,0
548,Lopinavir,SARS-COV-2,https://doi.org/10.1101/2020.03.09.20033068,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,0
549,Ritonavir,SARS-COV-2,https://doi.org/10.1101/2020.03.09.20033068,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,0
550,Ganciclovir,SARS-COV-2,https://doi.org/10.1101/2020.03.09.20033068,experimental,OCC(OCn1cnc2c1nc(N)[nH]c2=O)CO,135398740.0,0
551,Lopinavir/Ritonavir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C.O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,11979606.0,0
552,Chloroquine phosphate,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,OP(=O)(O)O.OP(=O)(O)O.CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,64927.0,0
553,Umifenovir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411.0,0
554,Hydroxychloroquine,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,OCCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,3652.0,0
555,Favipiravir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,Fc1c[nH]c(=O)c(n1)C(=O)N,492405.0,0
556,Methylprednisolone,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,OCC(=O)C1(O)CCC2C1(C)CC(O)C1C2CC(C2=CC(=O)C=CC12C)C,6741.0,0
557,Remdesivir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016.0,0
558,Oseltamivir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028.0,0
559,Baloxavir Marboxil,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,COC(=O)OCOc1c(=O)ccn2c1C(=O)N1CCOCC1N2C1c2ccccc2SCc2c1ccc(c2F)F,124081896.0,0
560,Thalidomide,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)cccc2,5426.0,0
561,Darunavir,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,213039.0,0
562,cobicistat,SARS-COV-2,https://doi.org/10.1101/2020.03.18.20038190,experimental,O=C(NC(Cc1ccccc1)CCC(Cc1ccccc1)NC(=O)C(NC(=O)N(Cc1csc(n1)C(C)C)C)CCN1CCOCC1)OCc1cncs1,25151504.0,0
563,Thymosin,SARS-COV-2,10.1101/2020.03.18.20038190v2,,NCCCCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)O)CCC(=O)O)C)CCC(=O)O)CCC(=O)O)C(C)C)C(C)C)CCC(=O)O)CCCCN)CCCCN)CCC(=O)O)CCCCN)CC(C)C)CC(=O)O)NC(=O)C(C(C)C)NC(=O)C(C(O)C)NC(=O)C(C(CC)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(C(C)C)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(CS)N)CO)CC(=O)O)C)C)CC(=O)O)CO)CO)CCC(=O)O,44286042.0,0
564,hydroxychloroquine,SARS-COV-2,10.1101/2020.03.25.008482v1,,OCCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,3652.0,0
565,chloroquine phosphate,SARS-COV-2,10.1101/2020.03.25.008482v1,,OP(=O)(O)O.OP(=O)(O)O.CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,64927.0,0
566,Decitabine,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,OCC1OC(CC1O)n1cnc(nc1=O)N,451668.0,0
567,Omeprazole,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,COc1ccc2c(c1)[nH]c(n2)S(=O)Cc1ncc(c(c1C)OC)C,4594.0,0
568,Icatibant,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,OCC(C(=O)N1Cc2ccccc2CC1C(=O)N1C2CCCCC2CC1C(=O)NC(C(=O)O)CCCN=C(N)N)NC(=O)C(Cc1cccs1)NC(=O)CNC(=O)C1CC(CN1C(=O)C1CCCN1C(=O)C(NC(=O)C(CCCN=C(N)N)N)CCCN=C(N)N)O,6918173.0,0
569,Atazanavir,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192.0,0
570,Ceftolozane,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,NCCNC(=O)Nc1c[n+](n(c1N)C)CC1=C(C(=O)[O-])N2C(SC1)C(C2=O)NC(=O)C(=NOC(C(=O)O)(C)C)c1nsc(n1)N,53234134.0,0
571,Hesperidin,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,COc1ccc(cc1O)C1CC(=O)c2c(O1)cc(cc2O)OC1OC(COC2OC(C)C(C(C2O)O)O)C(C(C1O)O)O,10621.0,0
572,Carfilzomib,SARS-COV-2,10.20944/preprints202003.0279.v1,experimental,CC(CC(C(=O)NC(C(=O)NC(C(=O)C1(C)CO1)CC(C)C)Cc1ccccc1)NC(=O)C(NC(=O)CN1CCOCC1)CCc1ccccc1)C,11556711.0,0
573,Oseltamivir,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,CCOC(=O)C1=CC(C(C(C1)N)NC(=O)C)OC(CC)CC,65028.0,0
574,Lopinavir,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,0
575,Ritonavir,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,0
576,Ganciclovir,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,OCC(OCn1cnc2c1nc(N)[nH]c2=O)CO,135398740.0,0
577,Remdesivir,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016.0,0
578,Chloroquine,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719.0,0
579,EIDD-2801,SARS-COV-2,10.1016/j.jaut.2020.102433,experimental,ONc1ccn(c(=O)n1)C1OC(C(C1O)O)COC(=O)C(C)C,145996610.0,0
580,Cepharanthine,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,COc1cc2CCN(C3c2cc1Oc1c2c(CCN(C2Cc2ccc(Oc4cc(C3)ccc4OC)cc2)C)cc2c1OCO2)C,10206.0,0
581,Tegobuvir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,Fc1ccccc1c1nc2c(n1)cn(cc2)Cc1ccc(nn1)c1ccc(cc1C(F)(F)F)C(F)(F)F,23649154.0,0
582,Saquinavir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243.0,0
583,Tipranavir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CCCC1(CCc2ccccc2)CC(=C(C(=O)O1)C(c1cccc(c1)NS(=O)(=O)c1ccc(cn1)C(F)(F)F)CC)O,54682461.0,0
584,Lonafarnib,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,Clc1cc(Br)c2c(c1)CCc1c(C2C2CCN(CC2)C(=O)CC2CCN(CC2)C(=O)N)ncc(c1)Br,148195.0,0
585,Filibuvir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CCc1cc(CCC2(CC(=C(C(=O)O2)Cc2nn3c(n2)nc(cc3C)C)O)C2CCCC2)cc(n1)CC,54708673.0,0
586,Olysio,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,COc1ccc2c(c1C)nc(cc2OC1CC2C(C1)C(=O)N(C)CCCCC=CC1C(NC2=O)(C1)C(=O)NS(=O)(=O)C1CC1)c1scc(n1)C(C)C,24873435.0,0
587,Beclabuvir,SARS-COV-2,preprints202002.0418.v2,computational,COc1ccc2c(c1)C1CC1(Cn1c2c(C2CCCCC2)c2c1cc(cc2)C(=O)NS(=O)(=O)N(C)C)C(=O)N1C2CCC1CN(C2)C,49773361.0,0
588,Saquinavir,SARS-COV-2,preprints202002.0418.v2,computational,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243.0,0
589,Methylprednisolone,SARS-COV-2,preprints202002.0418.v2,computational,OCC(=O)C1(O)CCC2C1(C)CC(O)C1C2CC(C2=CC(=O)C=CC12C)C,6741.0,0
590,Thalidomide,SARS-COV-2,preprints202002.0418.v2,computational,O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)cccc2,5426.0,0
591,Nilotinib,SARS-COV-2,preprints202002.0418.v2,computational,Cc1ncn(c1)c1cc(NC(=O)c2ccc(c(c2)Nc2nccc(n2)c2cccnc2)C)cc(c1)C(F)(F)F,644241.0,0
592,Tadalafil,SARS-COV-2,preprints202002.0418.v2,computational,O=C1N(C)CC(=O)N2C1Cc1c(C2c2ccc3c(c2)OCO3)[nH]c2c1cccc2,110635.0,0
593,Lifitegrast,SARS-COV-2,preprints202002.0418.v2,computational,OC(=O)C(NC(=O)c1c(Cl)cc2c(c1Cl)CCN(C2)C(=O)c1ccc2c(c1)occ2)Cc1cccc(c1)S(=O)(=O)C,11965427.0,0
594,Digitoxin,SARS-COV-2,preprints202002.0418.v2,computational,O=C1OCC(=C1)C1CCC2(C1(C)CCC1C2CCC2C1(C)CCC(C2)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)O)O,441207.0,0
595,Tirilazad,SARS-COV-2,preprints202002.0418.v2,computational,O=C1C=CC2(C(=C1)CCC1C2=CCC2(C1CC(C2C(=O)CN1CCN(CC1)c1cc(nc(n1)N1CCCC1)N1CCCC1)C)C)C,104903.0,0
596,Danoprevir,SARS-COV-2,10.1101/2020.03.22.20034041,experimental,O=C(OC(C)(C)C)NC1CCCCCC=CC2C(NC(=O)C3N(C1=O)CC(C3)OC(=O)N1Cc3c(C1)cccc3F)(C2)C(=O)NS(=O)(=O)C1CC1,11285588.0,0
597,Ritonavir,SARS-COV-2,10.1101/2020.03.22.20034041,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,0
598,Catechin Gallate,SARS,10.2147/IJN.S31379,experimental,Oc1cc(O)c2c(c1)OC(C(C2)OC(=O)c1cc(O)c(c(c1)O)O)c1ccc(c(c1)O)O,6419835.0,0
599,Gallocatechin Gallate,SARS,10.2147/IJN.S31379,experimental,Oc1cc(O)c2c(c1)OC(C(C2)OC(=O)c1cc(O)c(c(c1)O)O)c1cc(O)c(c(c1)O)O,199472.0,0
600,Lopinavir,SARS/MERS,10.1016/j.antiviral.2013.08.015,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,0
601,Ritonavir,SARS/MERS,10.1016/j.antiviral.2013.08.015,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,0
602,Losartan,SARS-CoV-2,10.1002/ddr.21656,experimental,CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)CO)Cl,3961.0,0
603,Telmisartan,SARS-CoV-2,10.1002/ddr.21656,experimental,CCCc1nc2c(n1Cc1ccc(cc1)c1ccccc1C(=O)O)cc(cc2C)c1nc2c(n1C)cccc2,65999.0,0
604,Chloroquine,SARS-CoV-2,10.1002/ddr.21656,experimental,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719.0,0
605,Favipiravir,SARS-CoV-2,10.1002/ddr.21656,experimental,Fc1c[nH]c(=O)c(n1)C(=O)N,492405.0,0
606,Remdesivir,SARS-CoV-2,10.1002/ddr.21656,experimental,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016.0,0
607,Lopinavir,SARS-COV-2,10.31219/osf.io/hczra,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,0
608,Ritonavir,SARS-COV-2,10.31219/osf.io/hczra,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,0
609,Atazanavir,SARS-COV-2,10.31219/osf.io/hczra,experimental,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192.0,0
610,Carfilzomib,SARS-COV-2,10.31219/osf.io/hczra,experimental,CC(CC(C(=O)NC(C(=O)NC(C(=O)C1(C)CO1)CC(C)C)Cc1ccccc1)NC(=O)C(NC(=O)CN1CCOCC1)CCc1ccccc1)C,11556711.0,0
611,Cobicistat,SARS-COV-2,10.31219/osf.io/hczra,experimental,O=C(NC(Cc1ccccc1)CCC(Cc1ccccc1)NC(=O)C(NC(=O)N(Cc1csc(n1)C(C)C)C)CCN1CCOCC1)OCc1cncs1,25151504.0,0
612,Ombitasvir,SARS-COV-2,10.31219/osf.io/hczra,experimental,COC(=O)NC(C(=O)N1CCCC1C(=O)Nc1ccc(cc1)C1CCC(N1c1ccc(cc1)C(C)(C)C)c1ccc(cc1)NC(=O)C1CCCN1C(=O)C(C(C)C)NC(=O)OC)C(C)C,54767916.0,0
613,Lopinavir,SARS,10.1007+s10156-003-0296-9,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,0
614,Ritonavir,SARS,10.1007+s10156-003-0296-9,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,0
615,Ribavirin,SARS,10.1007+s10156-003-0296-9,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,0
616,Glycyrrhizin,SARS,10.1007+s10156-003-0296-9,experimental,OC1C(OC2OC(C(=O)O)C(C(C2O)O)O)C(OC(C1O)C(=O)O)OC1CCC2(C(C1(C)C)CCC1(C2C(=O)C=C2C1(C)CCC1(C2CC(C)(CC1)C(=O)O)C)C)C,14982.0,0
617,Chlorpromazine,MERS,1-s2.0-S235277141630074X,experimental,CN(CCCN1c2ccccc2Sc2c1cc(Cl)cc2)C,2726.0,0
618,Chloroquine,MERS,1-s2.0-S235277141630074X,experimental,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719.0,0
619,Beclabuvir,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,COc1ccc2c(c1)C1CC1(Cn1c2c(C2CCCCC2)c2c1cc(cc2)C(=O)NS(=O)(=O)N(C)C)C(=O)N1C2CCC1CN(C2)C,49773361.0,0
620,Saquinavir,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243.0,0
621,Methylprednisolone,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,OCC(=O)C1(O)CCC2C1(C)CC(O)C1C2CC(C2=CC(=O)C=CC12C)C,6741.0,0
622,Thalidomide,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,O=C1CCC(C(=O)N1)N1C(=O)c2c(C1=O)cccc2,5426.0,0
623,Nilotinib,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,Cc1ncn(c1)c1cc(NC(=O)c2ccc(c(c2)Nc2nccc(n2)c2cccnc2)C)cc(c1)C(F)(F)F,644241.0,0
624,Tadalafil,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,O=C1N(C)CC(=O)N2C1Cc1c(C2c2ccc3c(c2)OCO3)[nH]c2c1cccc2,110635.0,0
625,Lifitegrast,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,OC(=O)C(NC(=O)c1c(Cl)cc2c(c1Cl)CCN(C2)C(=O)c1ccc2c(c1)occ2)Cc1cccc(c1)S(=O)(=O)C,11965427.0,0
626,Digitoxin,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,O=C1OCC(=C1)C1CCC2(C1(C)CCC1C2CCC2C1(C)CCC(C2)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)O)O,441207.0,0
627,Tirilazad,SARS-COV-2,10.20944/preprints202002.0418.v2,computational,O=C1C=CC2(C(=C1)CCC1C2=CCC2(C1CC(C2C(=O)CN1CCN(CC1)c1cc(nc(n1)N1CCCC1)N1CCCC1)C)C)C,104903.0,0
628,Cepharanthine,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,COc1cc2CCN(C3c2cc1Oc1c2c(CCN(C2Cc2ccc(Oc4cc(C3)ccc4OC)cc2)C)cc2c1OCO2)C,10206.0,0
629,Tegobuvir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,Fc1ccccc1c1nc2c(n1)cn(cc2)Cc1ccc(nn1)c1ccc(cc1C(F)(F)F)C(F)(F)F,23649154.0,0
630,Saquinavir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243.0,0
631,Tipranavir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CCCC1(CCc2ccccc2)CC(=C(C(=O)O1)C(c1cccc(c1)NS(=O)(=O)c1ccc(cn1)C(F)(F)F)CC)O,54682461.0,0
632,Lonafarnib,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,Clc1cc(Br)c2c(c1)CCc1c(C2C2CCN(CC2)C(=O)CC2CCN(CC2)C(=O)N)ncc(c1)Br,148195.0,0
633,Filibuvir,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,CCc1cc(CCC2(CC(=C(C(=O)O2)Cc2nn3c(n2)nc(cc3C)C)O)C2CCCC2)cc(n1)CC,54708673.0,0
634,Olysio,SARS-COV-2,10.20944/preprints202003.0024.v1,computational,COc1ccc2c(c1C)nc(cc2OC1CC2C(C1)C(=O)N(C)CCCCC=CC1C(NC2=O)(C1)C(=O)NS(=O)(=O)C1CC1)c1scc(n1)C(C)C,24873435.0,0
635,Decitabine,SARS-COV-2,preprints202003.0239.v1,computational,OCC1OC(CC1O)n1cnc(nc1=O)N,451668.0,0
636,Omeprazole,SARS-COV-2,preprints202003.0239.v1,computational,COc1ccc2c(c1)[nH]c(n2)S(=O)Cc1ncc(c(c1C)OC)C,4594.0,0
637,Icatibant,SARS-COV-2,preprints202003.0239.v1,computational,OCC(C(=O)N1Cc2ccccc2CC1C(=O)N1C2CCCCC2CC1C(=O)NC(C(=O)O)CCCN=C(N)N)NC(=O)C(Cc1cccs1)NC(=O)CNC(=O)C1CC(CN1C(=O)C1CCCN1C(=O)C(NC(=O)C(CCCN=C(N)N)N)CCCN=C(N)N)O,6918173.0,0
638,Atazanavir,SARS-COV-2,preprints202003.0239.v1,computational,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192.0,0
639,Ceftolozane,SARS-COV-2,preprints202003.0239.v1,computational,NCCNC(=O)Nc1c[n+](n(c1N)C)CC1=C(C(=O)[O-])N2C(SC1)C(C2=O)NC(=O)C(=NOC(C(=O)O)(C)C)c1nsc(n1)N,53234134.0,0
640,Hesperidin,SARS-COV-2,preprints202003.0239.v1,computational,COc1ccc(cc1O)C1CC(=O)c2c(O1)cc(cc2O)OC1OC(COC2OC(C)C(C(C2O)O)O)C(C(C1O)O)O,10621.0,0
641,Carfilzomib,SARS-COV-2,preprints202003.0239.v1,computational,CC(CC(C(=O)NC(C(=O)NC(C(=O)C1(C)CO1)CC(C)C)Cc1ccccc1)NC(=O)C(NC(=O)CN1CCOCC1)CCc1ccccc1)C,11556711.0,0
642,Ribavirin,SARS,10.3201/eid1004.030458,experimental,OCC1OC(C(C1O)O)n1cnc(n1)C(=O)N,37542.0,0
643,Lopinavir,MERS,10.1038/nrd.2015.37,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,0
644,Ritonavir,MERS,10.1038/nrd.2015.37,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,0
645,Abemaciclib,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN1CCN(CC1)Cc1ccc(nc1)Nc1ncc(c(n1)c1cc(F)c2c(c1)n(C(C)C)c(n2)C)F,46220502.0,0
646,Amodiaquine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN(Cc1cc(ccc1O)Nc1ccnc2c1ccc(c2)Cl)CC,2165.0,0
647,Anidulafungin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCCCCOc1ccc(cc1)c1ccc(cc1)c1ccc(cc1)C(=O)NC1CC(O)C(O)NC(=O)C2C(O)C(CN2C(=O)C(NC(=O)C(NC(=O)C2N(C(=O)C(NC1=O)C(O)C)CC(C2)O)C(C(c1ccc(cc1)O)O)O)C(O)C)C,166548.0,0
648,Bazedoxifene,SARS-COV-2,10.1101/2020.03.20.999730,experimental,Oc1ccc2c(c1)c(C)c(n2Cc1ccc(cc1)OCCN1CCCCCC1)c1ccc(cc1)O,154257.0,0
649,Berbamine hydrochloride,SARS-COV-2,10.1101/2020.03.20.999730,experimental,COc1c(OC)cc2c3c1Oc1cc4c(cc1OC)CCN(C4Cc1ccc(Oc4cc(CC3N(CC2)C)ccc4O)cc1)C.Cl,56845155.0,0
650,Camostat,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CN(C(=O)COC(=O)Cc1ccc(cc1)OC(=O)c1ccc(cc1)N=C(N)N)C,2536.0,0
651,Cepharanthine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,COc1cc2CCN(C3c2cc1Oc1c2c(CCN(C2Cc2ccc(Oc4cc(C3)ccc4OC)cc2)C)cc2c1OCO2)C,10206.0,0
652,Chloroquine diphosphate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,OP(=O)(O)O.OP(=O)(O)O.CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,64927.0,0
653,Ciclesonide,SARS-COV-2,10.1101/2020.03.20.999730,experimental,O=C(C(C)C)OCC(=O)C12OC(OC1CC1C2(C)CC(O)C2C1CCC1=CC(=O)C=CC21C)C1CCCCC1,6918155.0,0
654,Clomiphene citrate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,OC(=O)C(CC(=O)O)(CC(=O)O)O.CCN(CCOc1ccc(cc1)C(=C(c1ccccc1)Cl)c1ccccc1)CC,3033832.0,0
655,Cyclosporine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC=CCC(C(C1C(=O)NC(CC)C(=O)N(C)CC(=O)N(C)C(CC(C)C)C(=O)NC(C(C)C)C(=O)N(C)C(CC(C)C)C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)O)C,5284373.0,0
656,Digitoxin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,O=C1OCC(=C1)C1CCC2(C1(C)CCC1C2CCC2C1(C)CCC(C2)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)O)O,441207.0,0
657,Digoxin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,O=C1OCC(=C1)C1CCC2(C1(C)C(O)CC1C2CCC2C1(C)CCC(C2)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)OC1CC(O)C(C(O1)C)O)O,2724385.0,0
658,Dihydrogambogic acid,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC(=CCc1c2OC34C5(CC=C(C(=O)O)C)OC(C4CC(C5O)C=C3C(=O)c2c(c2c1OC(C)(CCC=C(C)C)C=C2)O)(C)C)C,6857793.0,0
659,Droloxifene,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCC(=C(c1cccc(c1)O)c1ccc(cc1)OCCN(C)C)c1ccccc1,3033767.0,0
660,Dronedarone HCl,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCCCc1oc2c(c1C(=O)c1ccc(cc1)OCCCN(CCCC)CCCC)cc(cc2)NS(=O)(=O)C.Cl,219025.0,0
661,Ebastine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,O=C(c1ccc(cc1)C(C)(C)C)CCCN1CCC(CC1)OC(c1ccccc1)c1ccccc1,3191.0,0
662,Eltrombopag,SARS-COV-2,10.1101/2020.03.20.999730,experimental,OC(=O)c1cccc(c1)c1cccc(c1O)N=Nc1c(C)[nH]n(c1=O)c1ccc(c(c1)C)C,135449332.0,0
663,Gilteritinib,SARS-COV-2,10.1101/2020.03.20.999730,experimental,COc1cc(ccc1N1CCC(CC1)N1CCN(CC1)C)Nc1nc(NC2CCOCC2)c(nc1C(=O)N)CC,49803313.0,0
664,Hexachlorophene,SARS-COV-2,10.1101/2020.03.20.999730,experimental,Clc1cc(Cl)c(c(c1O)Cc1c(O)c(Cl)cc(c1Cl)Cl)Cl,3598.0,0
665,Hydroxyprogesterone caproate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCCCCC(=O)OC1(CCC2C1(C)CCC1C2CCC2=CC(=O)CCC12C)C(=O)C,169870.0,0
666,Isoosajin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,Oc1ccc(cc1)c1coc2c(c1=O)c1OC(C)(C)CCc1c1c2C=CC(O1)(C)C,1069873.0,0
667,Isopomiferin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,Oc1ccc(cc1O)c1coc2c(c1=O)c1OC(C)(C)CCc1c1c2C=CC(O1)(C)C,20055152.0,0
668,Ivacaftor,SARS-COV-2,10.1101/2020.03.20.999730,experimental,O=C(c1c[nH]c2c(c1=O)cccc2)Nc1cc(O)c(cc1C(C)(C)C)C(C)(C)C,16220172.0,0
669,Lanatoside C,SARS-COV-2,10.1101/2020.03.20.999730,experimental,OCC1OC(OC2C(C)OC(CC2OC(=O)C)OC2C(O)CC(OC2C)OC2C(O)CC(OC2C)OC2CCC3(C(C2)CCC2C3CC(O)C3(C2(O)CCC3C2=CC(=O)OC2)C)C)C(C(C1O)O)O,656630.0,0
670,LDK378,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC(Oc1cc(C2CCNCC2)c(cc1Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)C(C)C)Cl)C)C,57379345.0,0
671,Loperamid hydrochloride,SARS-COV-2,10.1101/2020.03.20.999730,experimental,Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1.Cl.Cl,67764865.0,0
672,Lopinavir,SARS-COV-2,10.1101/2020.03.20.999730,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,0
673,Lusutrombopag,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCCCCCOC(c1cccc(c1OC)c1csc(n1)NC(=O)c1cc(Cl)c(c(c1)Cl)C=C(C(=O)O)C)C,49843517.0,0
674,Mefloquine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,OC(c1cc(nc2c1cccc2C(F)(F)F)C(F)(F)F)C1CCCCN1,40692.0,0
675,Mequitazine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,c1ccc2c(c1)N(CC1CN3CCC1CC3)c1c(S2)cccc1,4066.0,0
676,Niclosamide,SARS-COV-2,10.1101/2020.03.20.999730,experimental,Clc1ccc(c(c1)C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])O,4477.0,0
677,Osajin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CC(=CCc1c2OC(C)(C)C=Cc2c2c(c1O)c(=O)c(co2)c1ccc(cc1)O)C,95168.0,0
678,Osimertinib mesylate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CS(=O)(=O)O.C=CC(=O)Nc1cc(Nc2nccc(n2)c2cn(c3c2cccc3)C)c(cc1N(CCN(C)C)C)OC,78357807.0,0
679,Ouabain,SARS-COV-2,10.1101/2020.03.20.999730,experimental,OCC12C(O)CC(CC2(O)CCC2C1C(O)CC1(C2(O)CCC1C1=CC(=O)OC1)C)OC1OC(C)C(C(C1O)O)O,439501.0,0
680,Oxyclozanide,SARS-COV-2,10.1101/2020.03.20.999730,experimental,Clc1cc(NC(=O)c2c(O)c(Cl)cc(c2Cl)Cl)c(c(c1)Cl)O,16779.0,0
681,Penfluridol,SARS-COV-2,10.1101/2020.03.20.999730,experimental,Fc1ccc(cc1)C(c1ccc(cc1)F)CCCN1CCC(CC1)(O)c1ccc(c(c1)C(F)(F)F)Cl,33630.0,0
682,Perhexiline maleate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C1CCC(NC1)CC(C1CCCCC1)C1CCCCC1.OC(=O)C=CC(=O)O,5284439.0,0
683,Phenazopyridine hydrochloride,SARS-COV-2,10.1101/2020.03.20.999730,experimental,Nc1ccc(c(n1)N)N=Nc1ccccc1.Cl,8691.0,0
684,Pralatrexate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,C#CCC(c1ccc(cc1)C(=O)NC(C(=O)O)CCC(=O)O)Cc1cnc2c(n1)c(N)nc(n2)N,148121.0,0
685,Proscillaridin,SARS-COV-2,10.1101/2020.03.20.999730,experimental,OC1C(OC2CCC3(C(=C2)CCC2C3CCC3(C2(O)CCC3c2ccc(=O)oc2)C)C)OC(C(C1O)O)C,5284613.0,0
686,Pyronaridine tetraphosphate,SARS-COV-2,10.1101/2020.03.20.999730,experimental,OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.OP(=O)(O)O.COc1ccc2c(n1)c(Nc1cc(CN3CCCC3)c(c(c1)CN1CCCC1)O)c1c(n2)cc(cc1)Cl,156867.0,0
687,Quinacrine hydrochloride,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN(CCCC(Nc1c2cc(OC)ccc2nc2c1ccc(c2)Cl)C)CC.Cl.Cl,6239.0,0
688,Remdesivir,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4,,0
689,"Salinomycin, sodium",SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCC(C1OC2(C=CC(C3(O2)CCC(O3)(C)C2CCC(C(O2)C)(O)CC)O)C(CC1C)C)C(=O)C(C(C(C1OC(CCC1C)C(C(=O)[O-])CC)C)O)C.[Na+],23682228.0,0
690,Tetrandrine,SARS-COV-2,10.1101/2020.03.20.999730,experimental,COc1c(OC)cc2c3c1Oc1cc4c(cc1OC)CCN(C4Cc1ccc(Oc4cc(CC3N(CC2)C)ccc4OC)cc1)C,73078.0,0
691,Thioridazine hydrochloride,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1.Cl,66062.0,0
692,Tilorone,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN(CCOc1ccc2c(c1)C(=O)c1c2ccc(c1)OCCN(CC)CC)CC,5475.0,0
693,Toremiphene,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3,3005573.0,0
694,Triparanol,SARS-COV-2,10.1101/2020.03.20.999730,experimental,CCN(CCOc1ccc(cc1)C(c1ccc(cc1)C)(Cc1ccc(cc1)Cl)O)CC,6536.0,0
695,Saquinavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,NC(=O)CC(C(=O)NC(C(CN1CC2CCCCC2CC1C(=O)NC(C)(C)C)O)Cc1ccccc1)NC(=O)c1ccc2c(n1)cccc2,441243.0,0
696,Atazanavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192.0,0
697,Lopinavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,0
698,Tipranavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CCCC1(CCc2ccccc2)CC(=C(C(=O)O1)C(c1cccc(c1)NS(=O)(=O)c1ccc(cn1)C(F)(F)F)CC)O,54682461.0,0
699,Amprenavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1CCOC1)O)C,65016.0,0
700,Fosamprenavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1CCOC1)OP(=O)(O)O)C,131536.0,0
701,Ritonavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,0
702,Darunavir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,213039.0,0
703,Paritaprevir,SARS-COV-2,10.1101/2020.04.05.20054254,computational,Cc1ncc(nc1)C(=O)NC1CCCCCC=CC2C(NC(=O)C3N(C1=O)CC(C3)Oc1nc3ccccc3c3c1cccc3)(C2)C(=O)NS(=O)(=O)C1CC1,45110509.0,0
704,Azithromycine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCC1OC(=O)C(C)C(OC2OC(C)C(C(C2)(C)OC)O)C(C)C(OC2OC(C)CC(C2O)N(C)C)C(CC(CN(C(C(C1(C)O)O)C)C)C)(C)O,447043.0,0
705,Opipramol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OCCN1CCN(CC1)CCCN1c2ccccc2C=Cc2c1cccc2,9417.0,0
706,Quinidine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C=CC1CN2CCC1CC2C(c1ccnc2c1cc(OC)cc2)O,441074.0,0
707,Omeprazol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COc1ccc2c(c1)[nH]c(n2)S(=O)Cc1ncc(c(c1C)OC)C,4594.0,0
708,Oxprenolol hydrochloride,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C=CCOc1ccccc1OCC(CNC(C)C)O.Cl,71172.0,0
709,Clemizole hydrochloride,SARS-COV-2,10.1101/2020.04.03.023846,mixed,Clc1ccc(cc1)Cn1c(CN2CCCC2)nc2c1cccc2.Cl,5309446.0,0
710,Alprostadil,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCCCC(C=CC1C(O)CC(=O)C1CCCCCCC(=O)O)O,5280723.0,0
711,Dolutegravir,SARS-COV-2,10.1101/2020.04.03.023846,mixed,Fc1ccc(c(c1)F)CNC(=O)c1cn2CC3OCCC(N3C(=O)c2c(c1=O)O)C,54726191.0,0
712,Sulfadoxine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COc1c(OC)ncnc1NS(=O)(=O)c1ccc(cc1)N,17134.0,0
713,Arbidol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCOC(=O)c1c(CSc2ccccc2)n(c2c1c(CN(C)C)c(O)c(c2)Br)C,131411.0,0
714,Remdesivir,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCC(COC(=O)C(NP(=O)(Oc1ccccc1)OCC1OC(C(C1O)O)(C#N)c1ccc2n1ncnc2N)C)CC,121304016.0,0
715,Oxymetholone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OC=C1CC2(C)C(CC1=O)CCC1C2CCC2(C1CCC2(C)O)C,5281034.0,0
716,Equilin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,Oc1ccc2c(c1)CC=C1C2CCC2(C1CCC2=O)C,223368.0,0
717,Pregnenolone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OC1CCC2(C(=CCC3C2CCC2(C3CCC2C(=O)C)C)C1)C,8955.0,0
718,Formestane,SARS-COV-2,10.1101/2020.04.03.023846,mixed,O=C1CCC2(C(=C1O)CCC1C2CCC2(C1CCC2=O)C)C,11273.0,0
719,Exemestane,SARS-COV-2,10.1101/2020.04.03.023846,mixed,O=C1C=CC2(C(=C1)C(=C)CC1C2CCC2(C1CCC2=O)C)C,60198.0,0
720,Methandrostenolone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,O=C1C=CC2(C(=C1)CCC1C2CCC2(C1CCC2(C)O)C)C,6300.0,0
721,Prednicarbate,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCOC(=O)OC1(CCC2C1(C)CC(O)C1C2CCC2=CC(=O)C=CC12C)C(=O)COC(=O)CC,6714002.0,0
722,Desonide,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OCC(=O)C12OC(OC1CC1C2(C)CC(O)C2C1CCC1=CC(=O)C=CC21C)(C)C,5311066.0,0
723,Misoprostol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCCC(CC=CC1C(O)CC(=O)C1CCCCCCC(=O)OC)(O)C,5282381.0,0
724,Vonoprazan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CNCc1cc(n(c1)S(=O)(=O)c1cccnc1)c1ccccc1F,15981397.0,0
725,Darunavir,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(CN(S(=O)(=O)c1ccc(cc1)N)CC(C(Cc1ccccc1)NC(=O)OC1COC2C1CCO2)O)C,213039.0,0
726,Prothionamide,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCc1cc(ccn1)C(=S)N,666418.0,0
727,Levofloxacin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN1CCN(CC1)c1c(F)cc2c3c1OCC(n3cc(c2=O)C(=O)O)C,149096.0,0
728,Enoxacin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCn1cc(C(=O)O)c(=O)c2c1nc(N1CCNCC1)c(c2)F,3229.0,0
729,Sparfloxacin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC1NC(C)CN(C1)c1c(F)c(N)c2c(c1F)n(cc(c2=O)C(=O)O)C1CC1,60464.0,0
730,D-cycloserine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,NC1CONC1=O,6234.0,0
731,L-Cycloserine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,NC1CONC1=O,449215.0,0
732,Spiramycin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,O=CCC1CC(C)C(C=CC=CCC(OC(=O)CC(C(C1OC1OC(C)C(C(C1O)N(C)C)OC1CC(C)(O)C(C(O1)C)O)OC)O)C)OC1CCC(C(O1)C)N(C)C,6419898.0,0
733,Cefamandole,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OC(C(=O)NC1C(=O)N2C1SCC(=C2C(=O)O)CSc1nnnn1C)c1ccccc1,456255.0,0
734,Benzathine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,N(Cc1ccccc1)CCNCc1ccccc1,8793.0,0
735,Merbromin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,O=C1OC2(c3c1cccc3)c1cc(Br)c(cc1Oc1c2cc(Br)c(c1[Hg])[O-])[O-].O.[Na+].[Na+],8505.0,0
736,Ifenprodil tartrate,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OC(C(C(=O)O)O)C(=O)O.Oc1ccc(cc1)C(C(N1CCC(CC1)Cc1ccccc1)C)O.Oc1ccc(cc1)C(C(N1CCC(CC1)Cc1ccccc1)C)O,656586.0,0
737,Nylidrin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(NC(C(c1ccc(cc1)O)O)C)CCc1ccccc1,4567.0,0
738,Cyclopentolate,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN(CCOC(=O)C(C1(O)CCCC1)c1ccccc1)C,2905.0,0
739,(S)-(-)-Propranolol hydrochloride,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OC(COc1cccc2c1cccc2)CNC(C)C.Cl,165193.0,0
740,Ranolazine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COc1ccccc1OCC(CN1CCN(CC1)CC(=O)Nc1c(C)cccc1C)O,56959.0,0
741,Candesartan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)c(ccc2)C(=O)O,2541.0,0
742,Olmesartan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1n[nH]nn1)C(=O)O)C(O)(C)C,158781.0,0
743,Ambrisentan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COC(C(C(=O)O)Oc1nc(C)cc(n1)C)(c1ccccc1)c1ccccc1,6918493.0,0
744,Fosinopril,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCC(=O)OC(C(C)C)OP(=O)(CC(=O)N1CC(CC1C(=O)O)C1CCCCC1)CCCCc1ccccc1,55891.0,0
745,Fenoldopam,SARS-COV-2,10.1101/2020.04.03.023846,mixed,Oc1ccc(cc1)C1CNCCc2c1cc(O)c(c2Cl)O,3341.0,0
746,Meptazinol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCC1(CCCCN(C1)C)c1cccc(c1)O,41049.0,0
747,Nalmefene hydrochloride,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C=C1CCC2(C34C1Oc1c4c(CC2N(CC3)CC2CC2)ccc1O)O.Cl,5388881.0,0
748,Mirtazapine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN1CCN2C(C1)c1ccccc1Cc1c2nccc1,4205.0,0
749,Olanzapine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN1CCN(CC1)C1=Nc2ccccc2Nc2c1cc(s2)C,135398745.0,0
750,Tacrine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,Nc1c2CCCCc2nc2c1cccc2,1935.0,0
751,Promazine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN(CCCN1c2ccccc2Sc2c1cccc2)C,4926.0,0
752,Clebopride,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COc1cc(N)c(cc1C(=O)NC1CCN(CC1)Cc1ccccc1)Cl,2780.0,0
753,Donepezil,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COc1cc2c(cc1OC)CC(C2=O)CC1CCN(CC1)Cc1ccccc1,3152.0,0
754,Tolperisone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(C(=O)c1ccc(cc1)C)CN1CCCCC1,5511.0,0
755,Idazoxan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,C1CN=C(N1)C1COc2c(O1)cccc2,54459.0,0
756,Ondansetron,SARS-COV-2,10.1101/2020.04.03.023846,mixed,O=C1C(CCc2c1c1ccccc1n2C)Cn1ccnc1C,4595.0,0
757,Eletriptan,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN1CCCC1Cc1c[nH]c2c1cc(cc2)CCS(=O)(=O)c1ccccc1,77993.0,0
758,Phentermine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(Cc1ccccc1)(N)C,4771.0,0
759,Buspirone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1,2477.0,0
760,Nabumetone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COc1ccc2c(c1)ccc(c2)CCC(=O)C,4409.0,0
761,Tolterodine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,Cc1ccc(c(c1)C(c1ccccc1)CCN(C(C)C)C(C)C)O,443879.0,0
762,Benoxinate,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC,4633.0,0
763,Meprylcaine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCNC(COC(=O)c1ccccc1)(C)C,4065.0,0
764,Dyclonine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCCCOc1ccc(cc1)C(=O)CCN1CCCCC1,3180.0,0
765,Eperisone,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCc1ccc(cc1)C(=O)C(CN1CCCCC1)C,3236.0,0
766,Cisatracurium,SARS-COV-2,10.1101/2020.04.03.023846,mixed,COc1cc2c(cc1OC)CC[N+](C2Cc1ccc(c(c1)OC)OC)(C)CCC(=O)OCCCCCOC(=O)CC[N+]1(C)CCc2c(C1Cc1ccc(c(c1)OC)OC)cc(c(c2)OC)OC,62887.0,0
767,Formoterol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,O=CNc1cc(ccc1O)C(CNC(Cc1ccc(cc1)OC)C)O,3083544.0,0
768,Ambroxol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OC1CCC(CC1)NCc1cc(Br)cc(c1N)Br,2132.0,0
769,Levalbuterol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OCc1cc(ccc1O)C(CNC(C)(C)C)O,123600.0,0
770,Dimenhydrinate,SARS-COV-2,10.1101/2020.04.03.023846,mixed,Clc1[nH]c2c(n1)n(C)c(=O)n(c2=O)C.CN(CCOC(c1ccccc1)c1ccccc1)C,10660.0,0
771,Tripelennamine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CN(CCN(c1ccccn1)Cc1ccccc1)C,5587.0,0
772,Chloroquine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,2719.0,0
773,Hydroxychloroquine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OCCN(CCCC(Nc1ccnc2c1ccc(c2)Cl)C)CC,3652.0,0
774,Artenimol,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OC1OC2OC3(C)CCC4C2(C(C1C)CCC4C)OO3,3000518.0,0
775,Dipivefrin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CNCC(c1ccc(c(c1)OC(=O)C(C)(C)C)OC(=O)C(C)(C)C)O,3105.0,0
776,Ethoxzolamide,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CCOc1ccc2c(c1)sc(n2)S(=O)(=O)N,3295.0,0
777,Oxiglutatione,SARS-COV-2,10.1101/2020.04.03.023846,mixed,O=C(NC(C(=O)NCC(=O)O)CSSCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N)CCC(C(=O)O)N,65359.0,0
778,Isotretinoin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(=CC=CC(=CC(=O)O)C)C=CC1=C(C)CCCC1(C)C,5282379.0,0
779,Anthralin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,Oc1cccc2c1C(=O)c1c(C2)cccc1O,2202.0,0
780,Ibudilast,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(C(=O)c1c(nn2c1cccc2)C(C)C)C,3671.0,0
781,Fursultiamine,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OCCC(=C(N(Cc1cnc(nc1N)C)C=O)C)SSCC1CCCO1,3002119.0,0
782,Anethole-trithione,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC=Cc1ccc(cc1)OC,637563.0,0
783,Zoledronic acid,SARS-COV-2,10.1101/2020.04.03.023846,mixed,OP(=O)(C(P(=O)(O)O)(Cn1cncc1)O)O,68740.0,0
784,Oxyphenisatin,SARS-COV-2,10.1101/2020.04.03.023846,mixed,Oc1ccc(cc1)C1(c2ccc(cc2)O)C(=O)Nc2c1cccc2,31315.0,0
785,Cyclofenil,SARS-COV-2,10.1101/2020.04.03.023846,mixed,CC(=O)Oc1ccc(cc1)C(=C1CCCCC1)c1ccc(cc1)OC(=O)C,2898.0,0
786,Lopinavir,SARS-COV-2,10.1101/2020.04.06.026476,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(N1CCCNC1=O)C(C)C)O)Cc1ccccc1)COc1c(C)cccc1C,92727.0,0
787,Nelfinavir,SARS-COV-2,10.1101/2020.04.06.026476,experimental,OC(C(NC(=O)c1cccc(c1C)O)CSc1ccccc1)CN1CC2CCCCC2CC1C(=O)NC(C)(C)C,64143.0,0
788,Merimepodib,SARS-COV-2,10.1101/2020.04.07.028589,experimental,COc1cc(ccc1c1cnco1)NC(=O)Nc1cccc(c1)CNC(=O)OC1COCC1,153241.0,0
789,Ebselen,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,O=c1c2ccccc2[se]n1c1ccccc1,3194.0,0
790,Disulfiram,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,CCN(C(=S)SSC(=S)N(CC)CC)CC,3117.0,0
791,Tideglusib,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,O=c1sn(c(=O)n1Cc1ccccc1)c1cccc2c1cccc2,11313622.0,0
792,Carmofur,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O,2577.0,0
793,Shikonin,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,CC(=CCC(C1=CC(=O)c2c(C1=O)c(O)ccc2O)O)C,479503.0,0
794,PX-12,SARS-COV-2,10.1038/s41586-020-2223-y,experimental,CCC(SSc1ncc[nH]1)C,219104.0,0
795,Amantadine,SARS-COV-2,10.1101/2020.04.05.026187,experimental,NC12CC3CC(C2)CC(C1)C3,2130.0,0
796,Atazanavir,SARS-COV-2,10.1101/2020.04.04.020925,experimental,COC(=O)NC(C(C)(C)C)C(=O)NN(Cc1ccc(cc1)c1ccccn1)CC(C(Cc1ccccc1)NC(=O)C(C(C)(C)C)NC(=O)OC)O,148192.0,0
797,Ritonavir,SARS-COV-2,10.1101/2020.04.04.020925,experimental,O=C(NC(C(CC(Cc1ccccc1)NC(=O)C(C(C)C)NC(=O)N(Cc1csc(n1)C(C)C)C)O)Cc1ccccc1)OCc1cncs1,392622.0,0
798,Spermidine,SARS-COV-2,10.1101/2020.04.15.997254,experimental,NCCCNCCCCN,1102.0,0
799,MK-2206,SARS-COV-2,10.1101/2020.04.15.997254,experimental,O=c1[nH]nc2n1ccc1c2cc(c(n1)c1ccc(cc1)C1(N)CCC1)c1ccccc1,24964624.0,0
800,Niclosamide,SARS-COV-2,10.1101/2020.04.15.997254,experimental,Clc1ccc(c(c1)C(=O)Nc1ccc(cc1Cl)[N+](=O)[O-])O,4477.0,0
801,Amodiaquine,SARS-COV-2,10.1101/2020.04.13.039917,experimental,CCN(Cc1cc(ccc1O)Nc1ccnc2c1ccc(c2)Cl)CC,2165.0,0
802,Toremifene,SARS-COV-2,10.1101/2020.04.13.039917,experimental,ClCCC(=C(c1ccccc1)c1ccc(cc1)OCCN(C)C)c1ccccc1,3005573.0,0
